Northern Michigan University

NMU Commons
All NMU Master's Theses

Student Works

7-2017

CHARACTERIZATION OF TRANSMEMBRANE PROTEIN 35
EXPRESSION: CONSIDERATIONS OF SEX AND OVARIAN
HORMONES
Amanda M. Vanderplow
avanderp@nmu.edu

Follow this and additional works at: https://commons.nmu.edu/theses
Part of the Animals Commons, Animal Studies Commons, Behavior and Behavior Mechanisms
Commons, and the Nervous System Commons

Recommended Citation
Vanderplow, Amanda M., "CHARACTERIZATION OF TRANSMEMBRANE PROTEIN 35 EXPRESSION:
CONSIDERATIONS OF SEX AND OVARIAN HORMONES" (2017). All NMU Master's Theses. 155.
https://commons.nmu.edu/theses/155

This Open Access is brought to you for free and open access by the Student Works at NMU Commons. It has been
accepted for inclusion in All NMU Master's Theses by an authorized administrator of NMU Commons. For more
information, please contact kmcdonou@nmu.edu,bsarjean@nmu.edu.

CHARACTERIZATION OF TRANSMEMBRANE PROTEIN 35 EXPRESSION: CONSIDERATIONS OF
SEX AND OVARIAN HORMONES

By

Amanda M. Vanderplow

THESIS
Submitted to
Northern Michigan University
In partial fulfillment of the requirements
For the degree of

MASTER OF SCIENCE

Office of Graduate Education and Research

August 2017

SIGNATURE APPROVAL FORM

(CHARACTERIZATION OF TRANSMEMBRANE PROTEIN 35 EXPRESSION: CONSIDERATIONS OF
SEX AND OVARIAN HORMONES)

This thesis by Amanda M. Vanderplow is recommended for approval by the student’s Thesis
Committee and Department Head in the Department of Biology and by the Interim Director of
Graduate Education and Research.

__________________________________________________________
Committee Chair: Dr. Valerie Hedges
Date

__________________________________________________________
First Reader: Dr. John Rebers
Date

__________________________________________________________
Second Reader (if required): Dr. Erich Ottem
Date

__________________________________________________________
Department Head: Dr. John Rebers
Date

__________________________________________________________
Dr. Lisa S. Eckert
Date
Interim Director of Graduate Education and Research

ABSTRACT

CHARACTERIZATION OF TRANSMEMBRANE PROTEIN 35 EXPRESSION: CONSIDERATIONS OF
SEX AND OVARIAN HORMONES

By

Amanda M. Vanderplow

The recently discovered novel neuropeptide transmembrane protein 35 (TMEM35), is
believed to modulate chemical signaling within the nervous system. Notably, the TMEM35
protein is detectable in humans, non-human primates and rodents, suggesting a conserved and
critical function. Despite this, the functions of TMEM35 are ill-defined in the nervous system
and insufficiently studied (currently only three publications). Previous work has identified high
expression of TMEM35 in both the ventromedial hypothalamus (VMH) and the limbic circuit of
the mouse brain. Due to the known functions of these two regions, this pattern of expression
indicates possible roles of this neuropeptide in social behavior and reward processing.
Interestingly, TMEM35 mRNA expression exhibits possible sexual dimorphisms in rodents with
the overall expression of TMEM35 mRNA being higher in females than in males. However, this
qualitative evaluation of sex differences in mRNA expression has not been quantitatively
described throughout the brains of male and female rodents. We aimed to anatomically map
TMEM35 protein expression in both male and female Syrian hamsters to determine sex
differences in expression. Moreover, we hypothesized that ovarian hormones were responsible

i

for the observed sex differences in females. To determine this, we ovariectomized adult female
Syrian hamsters to remove the major endogenous source of gonadal steroid hormones, and
primed them with estradiol and progesterone to mimic the natural hormonal cycle, or with
cottonseed oil vehicle. Tissue was immunohistochemically processed for TMEM35-positive
cells. Sex differences in TMEM35 protein expression in which females expressed higher levels
than males were found in several brain areas, including in the anterior hypothalamic nucleus
(AH), anteroventral periventricular nucleus (AVPV), bed nucleus of the stria terminalis (BNST),
dorsomedial hypothalamus (DMH), dorsal lateral septum (LSd), dorsal medial amygdala (MAd),
medial caudate (MCU), medial preoptic nucleus (MPN), nucleus accumbens core (NAcc),
nucleus accumbens shell (NAcsh), suprachiasmatic nucleus (SCN), and ventromedial
hypothalamus (VMH). Of these brain areas, ovarian hormones induced TMEM35 expression in
the AH, CA1 of the hippocampal formation, MAd, MCU, NAcsh, PVN, and VMHm. Characterizing
how TMEM35 expression is altered as a result of engaging in normal life experiences will give
insight into the biology of brain circuitry, and will provide better understanding into how these
systems function and could potentially lead to the development of therapeutic treatments to
alleviate dysfunctions within each network.
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CHAPTER ONE: INTRODUCTION AND LITERATURE REVIEW
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INTRODUCTION
The nervous system consists of two parts, the peripheral and central nervous system.
Neuronal cell-to-cell communication is performed by different molecules such as small
molecule neurotransmitters and neuropeptides. Specifically, once released within the brain,
neuropeptides act as neuromodulators to initiate several downstream physiological processes
including reproduction, pain, memory, reward pathways, feeding and water intake, and
sleep/wake cycles (Burbach, 2011). Additionally, neuropeptides exert several biological effects,
such as synaptogenesis, altering membrane excitability and inducing gene expression (Landgraf
& Neumann, 2004; Merighi et al., 2011; Theodosis, et al., 1986).

NEUROPEPTIDES
Neuropeptides represent a large group of small protein molecules that are produced
and released by neurons of the central nervous system (CNS). Neuropeptides are synthesized
from an inactive precursor protein, a pre-pro-peptide in the endoplasmic reticulum. The
precursor proteins are stored in large granule vesicles (LGV), or secretory granules, together
with processing enzymes that act on specific cleavage sites to cut out bioactive peptides. A
single precursor protein can give rise to multiple copies of the same neuropeptide and/or
different types of peptides. Notably, it is common that neuropeptides and other molecules (i.e.
small molecule neurotransmitters, growth factors, other neuropeptides) may coexist and are
sometimes stored within individual LGV in neurons (Salio et al., 2006).
The co-release of neuropeptides with other molecules has been shown to increase the
response of target neurons (Kupfermann, 1991). This synaptic communication can occur when
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target cells express two or more distinct receptors on the post-synaptic membrane (Merighi et
al., 2011; Salio et al., 2006). For example, when neuropeptides coexist with neurotransmitters,
the neuropeptides typically function through binding to G-protein coupled receptors (GPCR).
GPCRs contain seven transmembrane domains that have the ability to modulate intracellular
metabolism through the activation of their associated G proteins (Hamm & Gilchrist, 1996).
There are over 20 different subfamilies of G proteins, which are classified based on their subunits. Each receptor subtype can activate different G proteins that signal through distinct
pathways. Furthermore, one neuropeptide can bind to multiple receptors or different
neuropeptides can bind to one receptor, thus adding complexity to the possible signaling
pathways. Growth factors are among potential candidate modulatory neuropeptides (Burbach,
2011). For example, brain derived neurotrophic factor (BDNF) is secreted in its precursor form,
which has typical neuropeptide signal and cleavage sites (Yang et al., 2009). Both the precursor
(Pro-BDNF) and BDNF act on different receptors, neurotrophin receptor p75 NTR and
tropomyosin receptor kinase B isoform, respectively. Acting on different receptors allows both
pro-BDNF and BDNF to have different functional roles (Teng et al., 2005; Woo et al., 2005).
Many neuropeptides are produced and released from diverse neuronal populations in
the hypothalamus. These Neuropeptides in the have a variety of central and peripheral
(endocrine) functions. Further, the hypothalamus is comprised of distinct functional nuclei that
provide a connection with the body for the unique integration of functions such as temperature
control, eating behavior, stress response, and reproductive behavior and function. The limbic
system, brainstem and spinal cord all have reciprocal connections to the hypothalamus and
express neuropeptides and steroid hormone receptors (Vanderah & Gould, 2015). These
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connections and distinct populations of neurons expressing and secreting neuropeptides in the
hypothalamus play a role in eliciting a behavioral effect or a behavioral response evoked by
environmental stimuli. Two well-studied hypothalamic peptides that have a significant
influence on behavioral, physiological and neuroendocrine function are oxytocin (OXT) and
vasopressin (AVP). OXT and AVP are synthesized in the hypothalamus and are released into
circulation or are utilized as synaptic neuropeptides to act in the body or in the brain,
respectively. In the brain, oxytocin influences social behaviors, including maternal and bonding
behavior. Vasopressin has a role in social recognition and aggression. In addition, other
neuropeptides, such as neuropeptide Y (NPY) and orexin also have significant influences on
behavior and emotion. NPY is produced in the arcuate nucleus and is known to play a major
role in food intake; whereas orexin is synthesized in the lateral hypothalamus and is a regulator
of sleep/wake states via interactions with neuronal systems involved in emotion, reward and
homeostasis (see Ludwig, 2011).

TRANSMEMBRANE PROTEIN 35
Transmembrane protein 35 (TMEM35) is a recently discovered small novel
neuropeptide (18.4kDa) that is encoded by the transmembrane protein 35 gene, located on the
human X-chromosome at position Xq22.1 (Hawrylycz et al., 2012; Tran et al., 2010). The
TMEM35 gene was identified in the rat spinal cord (GenBank accession no: AAT08467.1) and
ventromedial hypothalamus transcriptome in the mouse brain (Kurrasch et al., 2007).
Subsequent work revealed high levels of TMEM35 mRNA expression in hypothalamic and limbic
regions of the brain, including the hippocampus and amygdala of rodents and humans
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(Kennedy et al., 2016). The precursor protein contains a signal peptide, with three hydrophobic
transmembrane domains, and an evolutionarily conserved p75NTF binding motif (Fig 1).
Moreover, TMEM35 localization has been indicated along the neurite and in the presynaptic
membrane, suggesting that the protein is released (Fig 2) (Kennedy et al., 2016; Tran et al.,
2010). Notably, TMEM35 is highly conserved across species, including humans, chimpanzee,
dog, cow, mouse, rat, chicken, zebrafish, Drosophila, mosquito and frog (Fig 3). Although
TMEM35 is largely conserved, the function of this protein remains poorly understood.

Figure 1. Full amino acid
sequence and diagram of
TMEM35 structure. A. 167-amino
acid sequence of TMEM35 with a
signal peptide, four hydrophobic
transmembrane domains (TM14), a p75NTF binding receptor
motif, SYVRAL (underlined
letters/pink) and a COOH terminal
polypeptide (blue). B. diagram of
TMEM35 structure. (REFSEQ:
accession NM_021637.2)
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Figure 2. TMEM35 localization. A. Image of ventromedial hypothalamic neurons immunoreactive for TMEM35.
Arrows indicate TMEM35 location along the neurite. B. Western blot showing TMEM35 in hippocampal
homogenate and in synaptosomal fraction (arrow). TMEM35 is co-segregated with the presynaptic protein VAMP1 but not with PSD-95-rich postsynaptic pellet. This indicates that TMEM35 is located pre-synaptically. (Kennedy et
al., 2016).

Figure 3. Sequence identity of
TMEM35 protein and DNA in
different species. Alignment
score of TMEM35 protein/DNA
sequence based on amino acid
identity shows high level of
evolutionary conservation
(REFSEQ: accession
NM_021637.2).
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A study by Tran et al. implicated a role for TMEM35 (alternatively known as TUF1) in
adrenal cortex-zona glomerulosa growth following sodium depletion. Further, this work showed
that a small protein with a potentially secreted peptide contained a highly-conserved motif
required for binding to the p75NGF receptor. This work also showed that the TUF1 43-54 peptide
had low-affinity binding for the p75NGF receptor in vitro (Tran et al., 2010).
Another study conducted in vitro using osteosarcoma cells (OSC) indicated a role for
TMEM35 in cell growth, migration, and cell cycle progression of OSC. Furthermore, this study
used the STRING database, a functional protein interaction network database, to investigate
potential proteins interacting with TMEM35. The STRING database suggested potential
associations with BDNF, calcitonin-related polypeptide , NPY, nerve growth factor (NGF), NGF
receptor, and vasoactive intestinal peptide (Fig 4) (Huang, et al., 2016).
Lastly, a study by our colleagues Kennedy et al. investigated the involvement of
TMEM35 in memory and fear. This work in mice demonstrated that deletion of TMEM35
impaired spatial learning and altered stress-related functions. TMEM35-knockout mice
exhibited deficits in long-term fear and spatial memories, heightened anxiety-like behavior,
high levels of corticosterone, and adrenal hyperplasia. Findings from this study also revealed
that TMEM35 is required for normal expression of synaptic proteins, including N-methyl Daspartate receptor subtype 2B or postsynaptic density protein-95, which are important in
synaptic remodeling and sculpting (Kennedy et al., 2016). Moreover, the authors hypothesized
that TMEM35 may play a role in the regulation of dendritic spine morphology, due to the
presence of the p75NTF receptor-binding motif in the protein sequence. This motif is conserved
among nerve growth factors, such as pro-BDNF/BDNF. Binding of BDNF at the p75NTF receptor
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has been previously demonstrated to have an important role in synaptic plasticity and
regulating spin and dendritic complexity of neurons of the hippocampal formation (Teng et al.,
2005; Woo et al., 2005). Interestingly, preliminary evidence from a Kennedy et al. indicated that
TMEM35 mRNA exhibits possible sexual dimorphisms in hypothalamic and limbic brain regions
of rodents, and that females tend to express higher levels than males.

Figure 4. Prediction of functional partners of
TMEM35 by the STRING database. The
STRING database contains predicted and
known protein direct and indirect
interactions. TMEM35 may be associated
with BDNF, brain-derived neurotropic factor;
CALCB, calcitonin-related polypeptide ;
NGF, nerve growth factor; NGFR, NGF
receptor; TMEM35, transmembrane protein
35; VIP, vasoactive intestinal peptide. (Huang
et al., 2016)

8

SEX
Sex refers to the genetic physiological and biological characteristics that describe
females and males. Sex differences range from obvious phenotypical characteristics to subtler
sexual dimorphisms that are less observable. These sex differences are a product of
environmental and biological influences, including sex chromosomes, prenatal steroid
hormones, immune system function, adult steroid hormone levels, and sex-based gene
expression (Hutchison, et al., 1999; Karaismailoğlu & Erdem, 2013).
The developing mammalian brain is largely organized through the actions of steroid
hormones of gonadal origin to produce sex differences that underlie adult reproductive
physiology and behavior. In rodents, studies have shown the dominate organizing signal is the
perinatal testosterone (androgen) surge (Konkle & McCarthy, 2011). In males, aromatization of
testosterone into estradiol in the brain drives masculinization and defeminization, an active
process affecting cellular differentiation and connectivity and producing male sex-specific
behaviors. Whereas, in females, the absence of this perinatal surge results a brain capable of
producing female sex-specific behaviors.
Sexual differences in various regions of the brain typically display dimorphisms on a
variety of levels (gene expression, cell number, cell size, etc.) which are sensitive and
responsive to organizational and activational effects of gonadal hormones, and are also
implicated in sex-specific behaviors (Lenz, et al., 2012). Some sex differences observed in
hormone and behavior may be due to differences in sex hormone effects on gene expression in
specific brain regions.
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In development, steroid hormones exert long-term effects on target cells that stimulate
differentiation, cell growth, and regulation and synthesis of proteins by binding to steroid
receptors in localized brain regions to influence behavior and physiology (Mangelsdorf et al.,
1995; Tetel, 2009). Sex steroids can be divided into three main classes, androgens, estrogens
and progestins. In adulthood, sex steroids also elicit or maintain sexual dimorphism in the brain
by binding to specific receptors. After steroid receptor (SR) activation via hormone binding, the
SR undergoes a conformational change, which induces them to dimerize, translocate to the
nucleus and bind to hormone response elements on DNA. Steroid receptors recruit additional
proteins (co-activator or co-repressors) to form a transcriptional complex that initiates gene
transcription and thereby protein expression (Tsai & O’Malley, 1994). In addition to this
genomic route of binding, there are non-genomic binding mechanisms that utilize membranebound receptors. At membrane receptors, steroid hormones, particularly ovarian hormones,
initiate rapid signaling pathways that involve secondary-messenger molecules, such as kinases
and proteases (Fig 5) (Castoria et al., 1999; Migliaccio et al., 1996, 1998; Petersen et al., 2013;
Vasudevan & Pfaff, 2008). Cytoplasmic kinase signaling modulates phosphorylation of SR and SR
co-regulators, and nuclear steroid signaling, resulting in either suppression or activation of
transcription.
Ovarian hormones, estrogens and progestins are primarily produced in and secreted by
the ovary. These hormones elicit actions on several target tissues within the peripheral and
central nervous system. Extra-ovarian actions in the hypothalamic-pituitary are extensively
studied and have been implicated in a variety of functions, including development, growth,
cognition and behavior. Estradiol and progesterone target defined neuronal populations of
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males and females that are essential for sex-typical displays in behavior (Baudry, Bi, & Aguirre,
2013; Becker, 2005; Petersen et al., 2013). Furthermore, estrogen and progesterone have
structural cellular effects on the brain; they stimulate neurite outgrowth, synaptogenesis, and
regulate cell survival (for review see Barth et al., 2015).
The influences of gonadal hormones on physiology and behavior are well documented.
Gonadectomy (removal of the gonads) in both sexes produces a virtual elimination of sexual
behavior, which can be restored by providing hormone replacement (Lisk & Heimann, 1980;
Lisk & Reuter, 1980), giving researchers a means of controlling reproductive behaviors. Work in
castrated male rodents showed that testosterone replacement restored sexual and aggressive
behaviors (Beeman, 1947). In females, ovarian hormones follow a 4-day estrous cycle, in which
estrogen and progesterone are released in a cyclical manner. In the rodent estrous cycle, there
is an initial increase in estradiol levels followed by a surge in circulating progesterone levels,
followed by a period of sexual responsivity (estrus). The binding of these ovarian hormones to
their respective receptors in the brain is necessary to elicit a behavioral response (Jeffrey D
Blaustein, 2002; Kow & Pfaff, 1975; D. Pfaff, 2005). The fluctuation and sequence of changes in
estradiol and progesterone levels modulate expression of female sexual responsiveness,
influence feelings of reward, and control ovulation (Valerie L. Hedges, et al., 2010a; Tsukahara,
et al., 2014; Wallace et al., 2008). In addition, ovarian hormones modulate the ventromedial
hypothalamus, which is known to play a role in controlling female sexual behavior (termed
lordosis), when exposed to a male counterpart (Cohen & Pfaff, 1992; Flanagan-Cato, 2011;
Malsbury et al., 1977). However, a female adult rodent will not display lordosis in the presence
of a male if their endogenous source of estradiol and progesterone is removed via an
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ovariectomy. But, if ovarian hormones are replaced, female typical behavior returns (Kow &
Pfaff, 1975; D. Pfaff, 2005). Sex differences are both dependent and independent of circulating
gonadal hormones, and research has shown examples of both within the brain (see reviews: de
Vries & Forger, 2015; Lenz et al., 2012; Ngun et al., 2011; Sakuma, 2009).
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Figure 5. Representation of genomic and non-genomic estrogen (E2) and progesterone (PG) receptor signaling
pathways. Estrogen receptor (ERα) and progesterone receptor (PR) can bind directly to DNA-specific elements
(genomic) or indirectly to other transcription factors (non-genomic). Blue arrows: mitogen-activated protein
kinases (MAPKs), JAK/STAT, SRC or phosphatidylinositol-3-kinase (PI3K). Red arrows: epidermal growth factor
receptor (EGFR) activation by epidermal growth factor (EGF) or mediated by ERα activates MAPKs, which in turn
can phosphorylate and activate ERα or PR. Protein kinase A (PKA) and PAK phosphorylate and activates ERα. Cyclic
AMP protein (CAMP); heparin-binding (HB); coactivator-associated arginine methyltransferase-1 (CARM1);
phosphorylation (P); membrane receptors (GPR30 and mPR). (Tanos, Rojo, Echeverria, & Brisken, 2012)
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Basic and preclinical research has historically been more often focused in males. An
analysis by Shansky and Woolley reported that of 1244 rodent-related research articles in 5
journals, ~32% studied only males, ~7% studied only females, and only ~4% studied both sexes
and stated whether there were any differences between them. The remainder of studies
analyzed lacked or failed to report difference or sex altogether (Shansky & Woolley, 2016).
Considering the possible role for sex in research is an essential step toward understanding the
brain at its most fundamental level. To understand biological processes that underlie human
disorders, it is of value to scientific research to consider sex as a biological variable and thus
how sex influences these same biological processes. Focusing on sex difference research will
inform numerous fields and clinical areas to better understand the ways in which males and
females differ in biology and lead to improved health outcomes in humans.

NEUROMODULATORY SYSTEMS
Sex differences in the function and structure of the brain are well documented within
brain circuits that regulate behavioral responses to salience of environmental stimuli.
Neuromodulatory systems, such as the mesolimbic dopamine system and social behavioral
network, collectively play an important role in social decision-making, reward processing and
behavioral regulation. Social interactions are a crucial component of life for most vertebrates.
While social behaviors are considerably diverse across species, certain behaviors are strongly
conserved. Work conducted by Newman proposed that social behaviors that are regulated by
the evolutionarily conserved network of limbic and hypothalamic regions in the brain form a
“social behavioral network” (Newman, 1999). However, social behavior must be rewarding
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(reinforcing) in order for an adaptive behavioral response. More recent work has supported
Newman’s hypothesis and indicated a role for the mesolimbic dopamine system in rewarding
social behavior (O’Connell & Hofmann, 2011).

Figure 6. The social decision-making network. The social decision-making network is comprised of both the social
behavior network (left), mesolimbic reward system (right), and areas involved in both systems (center). Arrows
indicate connections between brain regions in mammals. AH, anterior hypothalamus; blAMY, basolateral
amygdala; BNST/meAMY, bed nucleus of the stria terminalis/medial amygdala; HIP, hippocampus; LS, lateral
septum; NAcc, nucleus accumbens; PAG/CG, periaqueductal gray/central gray; POA, preoptic area; Str, striatum;
VMH, ventromedial hypothalamus; VP, ventral pallidum; VTA, ventral tegmental area. (O’Connell & Hofmann,
2011)

15

Mesolimbic dopamine pathway:
The mesolimbic dopamine system plays an important role in mediating rewarding
stimuli that provide motivation and reinforcement to engage in reward-seeking behavior
(Berridge, 2007; Morgane et al., 2005; Paredes, 2009; Pierce & Kumaresan, 2006; Pitchers et al.,
2010). The mesolimbic dopamine system (ML-DA) is a part of a large assemblage of brain
structures, known as the limbic system, which mediates motivation and reward (Fig 6). This
pathway consists of ascending dopaminergic neurons that originate in the ventral tegmental
area and innervate several structures, including the medial prefrontal cortex and the nucleus
accumbens (Morgane et al., 2005; Pierce & Kumaresan, 2006). These dopaminergic neurons
increase their firing when active, bathing their downstream targets in dopamine, regulating the
rewarding effects of natural rewards and experiences such as food, water, sex, and social
behavior (Berridge, 2007; Carlezon & Thomas, 2009; Valerie L. Hedges et al., 2010a; Pierce &
Kumaresan, 2006). Natural rewards are unconditioned incentive stimuli that reinforce behavior,
and in turn, increase the likelihood of the repeated occurrence of the behavior due to its
pleasure-associated effects. The drive to pursue and consume these rewards is highly
conserved across species (Kelley & Berridge, 2002; Morgane et al., 2005; Pierce & Kumaresan,
2006; Pitchers et al., 2010). Motivated behaviors, such as sexual behavior, alter the structure
and physiology of the brain through the activation of the ML-DA (Meisel & Mullins, 2006;
Pitchers et al., 2010; Wallace et al., 2008). Interestingly, ovarian hormones have also been
previously shown to modulate the ML-DA system in rodents, enhancing motivation for sex,
food and drug abuse (Becker, 2005, 2009; Everitt, 1990; Lisk & Reuter, 1980); Refer to Table 1.
for a more detailed review of functional roles for each brain region in regulating behaviors. The
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reward system and social behavioral network collectively play fundamental roles in the
regulation of behavior.

Social Behavioral Network:
The social behavioral network (SBN) is a subset of limbic system nuclei that plays a role
in regulating social behavior. This network is comprised of six interconnected regions: the
medial amygdala (MA), bed nucleus of the stria terminalis (BNST), anterior hypothalamus (AH),
medial preoptic nucleus (MPN; referred to POA in Fig 6), ventromedial hypothalamus (VMH),
lateral septum (LS) and periaqueductal gray/central gray (Fig 6) (Newman, 1999; O’Connell &
Hofmann, 2011). These brain regions are involved in the regulation of several social behaviors
and contain abundant sex steroid hormone receptors; refer to Table 1 for a more detailed
review of functional roles for each brain region in regulating behaviors. Additionally, in the SBN,
the areas that regulate sexually dimorphic behaviors also process chemosensory information
that can trigger short-term behavioral responses and long-term physiological changes
(Jouhanneau et al., 2013; Keller et al., 2009).
Several brain areas within this circuitry contain neurons that express sex steroid
receptors which have modulatory effects on social behavior, including reproductive, aggressive,
and parental behaviors (O’Connell & Hofmann, 2011). Reproductive behaviors that are
controlled by nuclei in these interconnected regions included the MPN in males, which plays a
central role in male sexual behavior. The MPN in males contributes to the drive to seek sex
(motivation component) and consummatory components of sex behavior (the physical
performance of mounts, intromissions, and ejaculations) (Hull & Dominguez, 2007; Stolzenberg
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& Numan, 2011). In females, the VMH mediates sexual behavior, namely female sexual posture
of lordosis (Cohen & Pfaff, 1992; Flanagan-Cato, 2011; Malsbury et al., 1977). The SBN and MLDA system are linked by reciprocal connections between several brain areas and these circuits
share the lateral septum and bed nucleus of the stria terminalis. Both nuclei have functional
roles in reward processing and social behavior. The amygdala is another region that has
interconnected nuclei in both the SBN (medial amygdala) and ML-DA (basolateral amygdala).
Together the ML-DA and SBN circuits constitute the social decision-making network that is
crucial across species in behavioral regulation in response to cues in the environment
(O’Connell & Hofmann, 2011).

Reproductive Pathway:
Social interactions are key components of reproductive physiology and behavior in
vertebrates (Parhar et al., 2016). Sex-specific social behaviors are strongly associated with
gonadal hormones. Secretion of gonadal hormones is regulated by the hypothalamus-pituitarygonadal (HPG) axis. The hypothalamus is a central region that is responsible for the regulation
of hormone synthesis and release via the pituitary gland. A pivotal neuropeptide involved in the
regulation of reproduction is the gonadotropin-releasing hormone (GnRH) (Schally et al., 1972).
GnRH-expressing neurons are the final common pathway of the hypothalamus, and in both
males and females, sex steroids exert homeostatic negative feedback on GnRH release. In
rodent models, GnRH has been shown to regulate reproductive behaviors, including male
mating behaviors and female lordosis (Rivier et al., 1981; Sakuma & Pfaff, 1980). In recent
years, myriad studies have investigated the influential role of neuropeptides in reproductive
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function. Specifically, kisspeptin and neurokinin B-expressing cells mediate negative feedback
effects of sex steroids on the HPG axis (Hrabovszky et al., 2011). These neuropeptides are
involved in GnRH secretion and in regulation of social behaviors in vertebrates. Further, there is
accumulating evidence suggesting that these neuropeptides, as well as a variety of others, may
directly modulate social behaviors by acting within areas of the brain, outside of the HPG axis
(Parhar et al., 2016).

OBJECTIVES
My thesis will concentrate on the novel TMEM35 protein within the brain. The
experiments in this thesis are designed to elucidate potential functions of TMEM35. We aimed
to define a more complete understanding of the distribution patterns of TMEM35 in the Syrian
hamster CNS while also investigating suggested sex differences in TMEM35 expression patterns.
Further, we sought to determine the effects of ovarian hormones on TMEM35 expression in
females.
The initial part of this thesis investigated the distribution patterns of TMEM35 protein in
male Syrian hamster brains. To do so, we developed a comprehensive anatomical map of
TMEM35 protein distribution patterns in the CNS. Second, we chose to assess the potential
sexual dimorphism in TMEM35 protein expression in 44 different brain regions where this
protein was highly expressed. The implicated sexual dimorphism in TMEM35 mRNA expression
was based on a qualitative observation and has not been quantitatively described in the brains
of male and female rodents. Finally, we sought to study the effects ovarian hormones have
TMEM35 expression in 15 regions of the brain in ovariectomized female Syrian hamsters. The
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anatomical patterns of TMEM35 in the rodent brain, coupled with known functions of the
selected structures, led us to study ovarian hormones potential effects on TMEM35 protein
expression.
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Table 1. Functional roles of brain regions involved in various systems regulating behaviors in mammals.

Region
AH

Functional Role
aggression, reproduction,
parental care
Initiation of ovulation and
luteinizing hormone surge
aggression, emotional learning,
parental care

Indicated sex difference

BNST

motivation, parental care,
reproduction, stress response

Males: larger volume,
more neurons

DMH
HIP

Reproduction, motivation
spatial learning

LS

emotional learning, social
recognition and affiliation,
parental care, reproduction
aggression, reproduction, social
recognition, parental care

AVPV
blAMY

meAMY

MPN

aggression, reproduction,
parental care

NAc

emotional learning, impulsivity,
motivation, parental care

PAG/CG

reproduction, vocalization

PVN

reproduction, parental care

SCN

Regulate estrous cycle

STR

compulsive behavior

VMH

aggression, reproduction,
parental care

VP

emotional learning, parental
care
motivation, reproduction,
parental care

VTA

References
(Bridges, Mann, & Coppeta, 1999; HaydenHixson & Ferris, 1991; Moss, 1971)

Females: larger volume,
more neurons
Male: greater spine
density

(Simerly, 2002)
(A. Lee, Clancy, & Fleming, 2000; A. W. Lee &
Brown, 2007; Rubinow, Drogos, & Juraska,
2009; Sacchetti, Lorenzini, Baldi, Tassoni, &
Bucherelli, 1999)
(Crestani, F, A, Guimarães, & L, 2010;
Markham, Norvelle, & Huhman, 2009; Perrin,
Meurisse, & Lévy, 2007)
(Kriegsfeld et al., 2006)

Sex difference in cognitive
function (sex dependent)
Males: denser vasopressin
fibers

Review: (Koss & Frick, 2017)

Males: larger volume and
more neurons
(hemisphere dependent)
Males: larger volume,
larger neurons, more
neurons
Females: more estradiol
receptors
Females: greater density
of dendritic spines (effects
of estradiol)

(Aragona & Wang, 2009; A. W. Lee & Brown,
2007; Newman, 1999)

Females: denser
innervation of kisspeptin
fibers
Females: more estradiol
receptors
Females: larger volume of
MCU
Males: larger volume
Females: estradiol
responsiveness

(De Vries & Al-Shamma, 1990; Hammock,
2015; Y. Liu, Curtis, & Wang, 2001; Tsukahara
et al., 2014; Xiao, Kondo, & Sakuma, 2005)

(Kuroda & Numan, 2014; Perrin et al., 2007;
Reddy, Estill, Meaker, Stormshak, & Roselli,
2014)

(Becker, 2016; Becker, Rudick, & Jenkins, 2001;
Carlezon & Thomas, 2009; A. W. Lee & Brown,
2007; Wallace et al., 2008)
(Jürgens, 2009; Tovote et al., 2016; Yamada &
Kawata, 2014)
(Marraudino et al., 2017)

(Vida et al., 2008)
(Becker et al., 2001; Clarke, Hill, Robbins, &
Roberts, 2011; Karaismailoğlu & Erdem, 2013;
Schilman, Klavir, Winter, Sohr, & Joel, 2010;
Yin, Knowlton, & Balleine, 2006)
(Bridges et al., 1999; Cohen & Pfaff, 1992; Sá,
Lukoyanova, & Madeira, 2009; Sá, Pereira,
Malikov, & Madeira, 2013)
(Numan & Woodside, 2010; Numan & Young,
2016; Stolzenberg & Numan, 2011)
(Seip & Morrell, 2009; Stolzenberg & Numan,
2011)
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CHAPTER TWO: ANATOMICAL MAPPING OF TMEM35 PROTEIN THROUGHOUT THE MALE
SYRIAN HAMSTER BRAIN
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INTRODUCTION
Neuropeptides are small proteins produced and released by neurons in the central and
peripheral nervous system that act on neural substrates (Burbach, 2011). Neuropeptides are
the largest group of cell-to-cell signaling molecules and each one has a unique distribution
pattern in the nervous system. These characteristics allow neuropeptides to play important
roles in several neural processes, such as food and water intake, circadian rhythms, sexual and
reproductive behavior, and thermoregulation (Burbach, 2011). Additionally, these chemical
messengers exert several different biological effects, such as gene transcription regulation,
which in turn influences membrane excitability and synaptogenesis (Landgraf & Neumann,
2004; Merighi et al., 2011; Theodosis et al., 1986).
Transmembrane 35 is a novel ~ 18 kDa peptide that is believed to modulate chemical
signaling within the nervous system (Kennedy et al., 2016). Transmembrane protein 35
(TMEM35) is produced from a precursor protein encoded by the transmembrane 35 gene that
was first identified in the rat spinal cord (GenBank accession no.: AAT08467.1) and mouse
ventromedial hypothalamus transcriptome in the brain (Kurrasch et al., 2007). Subsequent
work revealed high levels of TMEM35 mRNA expression in the hypothalamic and limbic regions
of the developing embryonic and adult mouse brain (Kennedy et al., 2016). These brain areas
are known to function in female sexual behavior and in both natural rewarding behaviors, such
as food or sex behaviors (Avena et al., 2008; Meisel & Mullins, 2006; Pitchers et al., 2010,
2013), and maladaptive rewards, such as addictive behaviors (Anselme, 2009; Pierce &
Kumaresan, 2006; Pitchers et al., 2013; Robinson & Kolb, 2004). Thus, the anatomical
expression pattern of TMEM35 suggests a putative role of TMEM35 in mediating both natural
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and maladaptive rewarding behaviors. However, the potential function of the high expression
levels of TMEM35 within hypothalamic and limbic brain areas have been poorly studied.
The precursor protein of TMEM35 contains a signal peptide, three hydrophobic
transmembrane domains and an evolutionarily conserved p75NTF binding motif (Kennedy et al.,
2016; Tran et al., 2010). Notably, TMEM35 is detectable within the adrenal cortex of rats,
rodent blood serum, monkey cerebral spinal fluid, and human cord blood, suggesting a
conserved and critical function (Kennedy et al., 2016; Tran et al., 2010). TMEM35 localization
has been indicated along the neurite and in the presynaptic neuron membrane, suggesting that
the peptide is both secreted and located within the membrane of cells (Kennedy et al., 2016).
Unfortunately, to date, the functions of TMEM35 remain largely unknown and are insufficiently
studied (Huang et al., 2016; Kennedy et al., 2016; Tran et al., 2010). One of these studies
implicated a role for TMEM35 (previously referred to as, TUF1) in neurite outgrowth in the
adrenal cortex in response to a low-sodium diet, while another determined that TMEM35
functions in contextual fear and spatial learning (Kennedy et al., 2016; Tran et al., 2010). Lastly,
a study by Huang et al. suggested a potential role for TMEM35 in osterosarcoma cell growth
and migration (Huang et al., 2016). Despite these understanding of TMEM35, there has not yet
been a thorough description of the anatomical expression of TMEM35 throughout the brain nor
a comprehensive understanding of the functions that TMEM35 has within our nervous system.
Complete anatomical mapping of TMEM35 protein throughout the mammalian central
nervous system (CNS) is necessary to more clearly define hypothalamic and limbic distribution
patterns, and identify additional brain areas of TMEM35 expression. The current incomplete
understanding of the distribution of TMEM35 protein in the CNS limits the capability to fully
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describe the functional role of this peptide. Identification of brain areas that display numerous
TMEM35 positive cells can help elucidate potential functions of TMEM35 within the brain. To
this end, we used a Syrian hamster model system to fully map TMEM35 protein expression
throughout the rodent brain. This goal was accomplished through immunohistochemical
analysis to examine highly detailed expression patterns of TMEM35 throughout the brain. Our
study will direct future investigations into further elucidating the functions of TMEM35 through
the identification of brain areas that show heavy peptide expression.

METHODS:
Animals:
A total of seven male Syrian hamsters (Mesocricetus auratas) were used at 50-80 days
of age in this study. Animals were generated through an IACUC-approved hamster-breeding
colony. All animals were housed in the animal facility at Northern Michigan University, grouphoused in numbers of 2-3 in plastic cages (10.2 in x 18.7 in x 8.2 in). The animal room was
maintained at a controlled temperature of 22oC with a 14:10 hour reversed light-dark schedule
(lights off between 1 and 11 p.m.). Food and water were available ad libitum. All procedures
used in this experiment were used in accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals and were approved by the Northern Michigan
University Institutional Animal Care and Use Committee.
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Perfusions:
Animals were deeply anesthetized using Isofluorane (4% in 100% O2, Henry Schein
Animal Health, Melville, NY, USA) for perfusion. The perfusion began when the animal did not
display any reaction to a noxious stimulus (toe pinch test). An incision through the skin and
muscle layers was made with scissors across the abdomen, taking care not to damage the liver
and other organs. Another incision was then made through the ribcage up the animal’s right
side, exposing the heart. The diaphragm was cut, at which time the animal ceased breathing. An
intracardial injection of heparin sulfate (1000 IU/mL, Sagent Pharmaceuticals, Shaumburg, IL,
USA) was made with a 26G X 3/8” needle into the left ventricle to prevent blood clotting during
perfusion. An 18G needle, attached to a perfusion pump, was then placed in the left ventricle of
the heart and 25mM phosphate buffered saline (PBS) was pumped into the heart. The right
atrium was then quickly cut to allow the blood to escape and drain. Each animal was perfused
intracardially with 25mM PBS for approximately 2 min (approx. 25 mL) until the liver cleared of
blood, followed by 4% paraformaldehyde in 25mM PBS for 20 minutes (approx. 500 mL).

Tissue Procedures:
Following perfusion, the brains were harvested from the skull and post-fixed in 4%
paraformaldehyde (2-3 hours), followed by an overnight incubation in a 10% sucrose
cryoprotectant solution in 25mM PBS and stored appropriately at 4 degrees C. Frozen brain
tissue was serially sectioned in 40-μm coronal sections using a Leica CM1850 Cryostat.
Alternating sections were collected into two separate six-netwell free-floating plates containing
25mM PBS + 0.1% bovine serum albumin (BSA; wash buffer).
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Immunohistochemistry:
Only one plate of free floating sections was utilized for this study, while the second plate
was stored in cryoprotectant for future studies. The one plate of free-floating sections used for
this study was washed three times for 10 minutes each in wash buffer. Tissue sections were
incubated for ~48 hours (~24 hours at room temperature and ~24 hours at 4oC) in a solution of
wash buffer containing 0.03% Triton-X-100, and primary antibody (rabbit anti-TMEM35152-167,
1:4500, gift from Dr. Phu Tran at the University of Minnesota). Following incubation in primary
antibody, sections were washed three times in wash buffer for 10 minutes each, and then
sections were incubated for 45 minutes at room temperature with a biotinylated-goat antirabbit IgG secondary antibody in wash buffer (1:200, Vector Laboratories, Burlingame, CA, USA)
with shaking. Following secondary antibody incubation, sections were rinsed again in wash
buffer for 10 minutes (3x), and incubated in an avidin-biotin horseradish peroxidase complex in
wash buffer (1:50, Vector Laboratories), shaking for 45 minutes at room temperature. Sections
were rinsed in wash buffer for 10 minutes, followed by a wash in Tris buffer (7.45 grams Trizma
pre-set crystals/L dd H2O; Sigma Aldrich, St. Louis, MO) for 10 minutes. The tissue was reacted
with 2mM 3, 3’ diaminobenzidine (DAB) solution in Tris buffer activated with 0.003% hydrogen
peroxide for five minutes. Sections were put through a final series of rinses with the Tris buffer
(10 minutes) and deionized water (2x 10-minute rinses) to stop the chromagen reaction. Finally,
sections were mounted on Adhesion Superfrost Plus slides (Brain Research Labs, Waban, MA)
and left to dry overnight. All sections were dehydrated through a series of 10-minute ethanol
washes (70%, 95%, 100%, 100%) cleared in CitriSolv (Fisher Scientific, Hampton, NH, USA), and
cover-slipped using DPX (Sigma-Aldrich Chemicals, St. Louis, MO, USA).
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Imaging and Data Collection:
Images of coronal sections were collected using a Ventana iScan HT slide scanner
(Ventana Medical Systems, INC., Tucson, AZ, USA). Images were prepared for publication using
Free Whole Slide Image Viewer – PMA.Start (Pathomation, Antwerpen, Belgium) and ImageJ.
Areas of TMEM35 expression were identified based on The Stereotaxic Atlas of the Golden
Hamster (Academic Press, Elsevier, Amsterdam, The Netherlands). Observations were
categorized depending on number of positive cells, and were quantified (colored) as described
below: high/strong expression of TMEM35-positive cells = red; moderate expression of
TMEM35-positve cells = yellow; low expression of TMEM35-positive cells=blue; negative for
expression=black. This categorization was determined qualitatively.

RESULTS:
Distribution of TMEM35-expressing cells in the central nervous system
Using a male Syrian hamster animal model, we investigated the anatomical pattern of
TMEM35-expressing cells throughout the CNS from the forebrain to the hindbrain/cerebellum.
TMEM35- positive cells were vastly distributed and showed various expression levels depending
on the region of the brain. The results of the distribution of TMEM35-expressing cells are
presented in Figure 7 (overview) and Figures 8-25 (individual images).
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FIGURE 7. Overview of TMEM35-expressing cells in the CNS. A series of immunohistochemically stained coronal sections from the
forebrain to the hindbrain/cerebellum of male Syrian hamsters. Scale bar: 1mm.
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FOREBRAIN
Olfactory System.
Many positive cells were detected in the olfactory bulb/system (Fig 8a-b). All parts of the
anterior olfactory nucleus had high levels of TMEM35 protein expression. The medial and
ventral parts of the anterior olfactory nucleus (AOD/L/M/P) were more strongly labeled (Fig 8ab), but only weak labeling in the glomerular layer of the accessory olfactory bulb (GIA; Fig 8a-b).

Cerebrum.
Motor cortex and Somatosensory cortex:
The motor cortex (M; Fig 9a-16b) and the somatosensory cortex (S1-2; Fig 10a-15b) contained
moderate signals in all regions. The signals in the primary (M1) and secondary (M2) motor
cortex were similar throughout the CNS.

Auditory cortex and visual cortex:
Weak signals were detected throughout the auditory cortex (AU; Fig 16a-19b). Weak TMEM35
expression was consistently detected in the visual cortex (V1, V2L/M; Fig 16a-19b), however the
medial secondary (V2M) and primary visual (V1) cortices expression was stronger than that of
the lateral secondary cortex (V2L).

Insular cortex and Sensory cortex:
The agranular insular cortex (AID/P/V; Fig 9a-17a) was strongly labeled, whereas the
dysgranular (DI; Fig 11b-13b) and granular insular (GI; Fig 11b-16b) cortices were weakly or
moderately labeled.
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Prefrontal cortex:
TMEM35 signals were detected in the prelimbic (PrL), infralimbic (IL), dorsal peduncular (DP),
and orbital cortices (ORB). The expression in the prelimbic, infralimbic and dorsal peduncular
cortices was strong, whereas orbital cortex expression was moderately weak (Fig 9a-11a).

Piriform cortex:
A high number of positive cells were detected consistently in the piriform cortex (Pir) from the
rostral to caudal region (Fig 9a-18b). Moderate cell expression was consistently detected in the
dorsal endopiriform nucleus (DEn), and weak expression was detected in the ventral
endopiriform nucleus (VEn; Fig 11b-16a).

Cingulate cortex:
The cingulate cortex (Cg) consistently displayed expression of TMEM35 from the cingulate
cortex to the retrosplenial cortex (RSA/G). Interestingly, the rostral region of the cingulate
cortex (i.e., cingulate cortex area 1 and 2, Cg1-2; Fig 9b-14a) had much higher consistent
expression compared to the caudal regions (RSA/G) (i.e., retrosplenial agranular and granular
cortices; Fig 14b-20b).

Hippocampus and dentate gyrus:
All areas of the hippocampus (CA1-3, DG) were labeled. Many positive cells were observed in
the CA1, CA2, CA3 and dentate gyrus (DG) regions (Fig 15a-21a). Nerve fibers in CA2 radiatum
layer and CA3 lucidum and radiatum layers were labeled more than other areas. Neural fibers in
the polymorphic layer of the dentate gyrus were also strongly labeled.
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Amygdala:
All the amygdaloid subnuclei and regions were either strongly or moderately labeled for cells
and fibers (Fig 14a-18b). Specifically, the basolateral amygdaloid nucleus (anterior and
posterior) (BLA/P), medial amygdaloid nucleus (MeAD/AV), anterior cortical amygdaloid
nucleus (ACo), and amygdalohippocampal area (AHi) were all strongly labeled.
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B

FIGURE 8. Detailed distribution of TMEM35-expressing cells in the olfactory bulb and forebrain. Serial coronal sections in male
Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 3-11); immunohistochemically stained images (left)
and the abbreviation-tagged images (right); list of abbreviations page 143 and is colored depending on the expression quantity: high
= red; moderate = yellow; low = blue; negative = white. Scale bar: 1 mm.
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B

FIGURE 9. Detailed distribution of TMEM35-expressing cells in the forebrain. Serial coronal sections in male Syrian hamster brains
(A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 3-11); immunohistochemically stained images (left) and the abbreviationtagged images (right); list of abbreviations page 143 and is colored depending on the expression quantity: high = red; moderate =
yellow; low = blue; negative = white. Scale bar: 1 mm.
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FIGURE 10. Detailed distribution of TMEM35-expressing cells in the striatum, nucleus accumbens, and forebrain. Serial coronal
sections in male Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 12-16); immunohistochemically
stained images (left) and the abbreviation-tagged images (right); list of abbreviations page 143 and is colored depending on the
expression quantity: high = red; moderate = yellow; low = blue; negative = white. Scale bar: 1 mm.
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B

FIGURE 11. Detailed distribution of TMEM35-expressing cells in the striatum, nucleus accumbens, and forebrain. Serial coronal
sections of male Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 12-16); immunohistochemically
stained images (left) and the abbreviation-tagged images (right); list of abbreviations page 143 and is colored depending on the
expression quantity: high = red; moderate = yellow; low = blue; negative = white. Scale bar: 1 mm
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Subcortical nuclei.
Bed nucleus of the stria terminalis:
High expression of TMEM35 was detected in all areas of the bed nucleus of the stria terminalis
(BNST, BNSTP I/L/M; Fig 12b-14a)

Mammillary bodies:
The dorsal premammilary nucleus (PMD) showed moderate to weak TMEM35 expression (Fig
18b), while the medial mammillary nucleus (MM) had very few TMEM35-expressing cells.
Interestingly, high TMEM35 expression was detected in the supramammillary nucleus (SUM; Fig
17b-18b) and the ventral premammillary nucleus (PMV) (Fig 17b-18a). Fibers were observed in
the premammilary nucleus (PMV) as well.

Septum:
The lateral septal nuclei (LS) showed strong TMEM35 expression. Expression was particularly
high in both the ventral (LSv), intermediate (LSi), and dorsal (LSd) septal nuclei (Fig 10b-13b).

Basal ganglia.
Claustrum, Globus pallidus, Substantia nigra:
Weak labeling was detected in the claustrum (Cl; Fig 10ba-14a) and moderate to weak in the
globus pallidus (GP; Fig 10b-15b). High or Moderate expression was observed in all parts of the
substantia nigra (SNC/L/R; Fig 17b-21a).
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Striatum.
Caudate and putamen:
There was consistent but weak labeling in the medial caudate and putamen (CPu; Fig 10a-15b).
Nucleus accumbens:
Strong labeling was observed in the nucleus accumbens (core, NAcc; and shell, NAcsh; Fig 10b12a).

Ventral Pallidum:
The ventral pallidum (VP) showed moderate to high labeling of TMEM35 expression (Fig 11b13b).

Other regions of the forebrain.
The nucleus of the diagonal band of Broca (NBD; Fig 12a-13b) and the organum vasculosum of
the lamina terminalis (OVLT; Fig 12a) had moderate expression levels. Strong labeling of the
tenia tecta (DTT/VTT) was detected, where the dorsal portions were more strongly labeled than
the ventral portions (Fig 9a-10a). The lateral and ventral portions of the entorhinal cortex
(L/VEnt) were moderately or strongly labeled (Fig 18a-21b).

Diencephalon.
Epithalamus:
Strong to moderate labeling was detected in the habenula nuclei (Hb). The medial habenular
nucleus was more strongly stained than the lateral portion (Fig 15a-16b).
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Anterior nucleus group/Thalamus:
The anteroventral thalamic nucleus (AV; Fig. 15a) and anterodorsal thalamic nucleus (AD; Fig
15a) both had moderate expression. Weak expression was observed in the mediodorsal (MD)
and lateral dorsal thalamic nucleus (LD) (anterior part) (Fig 14b) Whereas, no expression was
detected in the anteromedial thalamic nucleus (dorsal and lateral) (AM; Fig 14b).

Ventrolateral nucleus group/Thalamus:
No detection was observed in the ventral posterior thalamic nuclei (i.e., posterolateral ventral
(VP M/L; Fig 14b-17a) and posteromedial (PoMn; Fig. 16a)). Strong labeling was detected in the
reticular thalamic nucleus (Rt; Fig 14a-16b).

Medial nucleus group/Thalamus:
The anterior and posterior portions of the paraventricular thalamic nuclei (PVA/P) contained
strong expression levels in both the cells and fibers (Fig 14a-17b). Abundant expression was
also observed in the central medial thalamic nucleus (CM; Fig 15a-16b) and interanterior
thalamic nuclei (IAM, IMD) (dorsal and medial parts (Fig 15a-15b). Weak labeling was observed
in the medial geniculate nucleus (MG) was observed (Fig. 18). Moderate expression was
observed in the xiphoid thalamic nucleus (Xi; Fig 14a-15b).

Preoptic area/Hypothalamus:
High expression of TMEM35-positive cells were observed in the medial preoptic nucleus and
area (MPN; Fig 14a-b). A moderate number of labeled cells were identified in the anteroventral
periventricular nucleus (AVPV; Fig 12b) and median preoptic nuclei (MnPO; Fig 13a). Weak

39

expression was observed in the lateral preoptic area (LPO; Fig 13a-b). Fibers were observed in
the medial preoptic nucleus (MPN) and anteroventral periventricular nucleus (AVPV).

Medial zone/Hypothalamus:
In the medial zone, high labeling for positive cells and nerve fibers for TMEM35 was identified
in the paraventricular nucleus (PVN; Fig 14b-15a), suprachiasmatic nucleus (SCN; Fig 14a-b),
supraoptic nucleus (SON; Fig 14a-15b), ventromedial hypothalamic nucleus (VMH; Fig 16a-b),
dorsomedial hypothalamic nucleus (DMH; Fig 16a-17a), and arcuate (ARC; Fig 16a-18a).
Additionally, the anterior hypothalamic nucleus (AH) contained a high expression for positive
cells (Fig 41a-15a).

Lateral Zone/Hypothalamus
The lateral hypothalamic nucleus (LH) had weak expression for TMEM35 from rostral to caudal
regions (Fig 14a-16b; 18a). The lateral (ZIL; Fig 18b) and medial (ZIM; Fig 15b) portions of the
zona incerta were weakly labeled.

MIDBRAIN/PONS
Midbrain.
Signals in the midbrain were detected over a wide range, and various expression levels were
observed. The retrorubral field (RRF; Fig 21a), inferior colliculus (central) (CIC; Fig 22a-b),
inferior colliculus (external) (ECIC; Fig 21a-22b), inferior colliculus (brachium) (BIC; Fig 20a-21a),
trochlear (4; Fig 21b), oculomotor (3; Fig 20b-21a), medial accessory oculomotor (MA3; Fig 18b)
nuclei were weakly labeled.

40

Ventral tegmental area:
Many positive cells were observed in the ventral tegmental area (VTA; Fig 19b-20b).

Substantia nigra:
Moderate to high expression levels were observed in the caudal region of the substantia nigra
(SN C/L/R; Fig 17b-21a)

Red Nucleus:
Moderate to high expression levels of positive cells were observed in magnocellular (RMC; Fig
19a-21a) and paravicellular (PCRt) parts of the red nucleus (Fig 23b)

Other regions of the midbrain.
High labeling was observed in the intermediate subnucleus of the interpeduncular nucleus (IPI;
Fig 21a). Weak levels of positive cells were observed in the nucleus of Darkschewitsh (DK; 17b20a), Edinger-Westphal (EW; Fig 18a-20b), and the lateral and dorsolateral parts of the
periaqueductal gray (L/D PAG; Fig 17b-22a). The caudal (IPC; Fig 19b-20b), lateral (IPL; Fig 21a),
dorsomedial (IPDM; Fig 20b-21a), and dorsolateral (IPDL; Fig 21c) portions of the
interperipeduncular nuclei were moderately or weakly labeled.

Pons.
Tegmental nuclei:
All areas of the tegmental nuclei (DMTg, LDTg PPTg, RtTg, PDTg) were (Fig 22a-23b) weakly or
moderately labeled. The ventral tegmental nucleus was strongly labeled (VTg; Fig 22a-22b).
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Vestibular nuclei:
The lateral vestibular nucleus (LVe; Fig 23b-25a), superior vestibular nucleus (SuVe; Fig 23b24a) medial vestibular (MVe; Fig 24a-25a), and spinal vestibular nucleus (SpVe; Fig 25b) were all
weakly labeled.

Ventral pons:
The pontine nucleus (Pn; Fig 21a-22a) was strongly labeled. The superior olive (SO; 22b-23b),
paraolivary nucleus (PO; Fig 24b) and rostral periolivary region (RPO; Fig 21b-22b) were
moderately labeled. The trapezoid body (Tz) was weakly labeled (Fig 23b-24a).

Dorsal pons:
Weakly-labeled cells were observed in the Barrington’s (Bar), locus coeruleus (LC; Fig 23a-24a),
abducens (6; Fig 24a), prepositus (Pr; 24b-25b), The pontine oral part (PnO; 21b-22b), pontine
caudal part (PnC; 23a-b), and paravicellular reticular nucleus (PCRt; Fig 23b-24a). The dorsal
paragigantocellular (DPGi) and the gigantocellular reticular nuclei (Gi) were moderately or
weakly labeled (Fig 24a-25b). The facial (7; Fig 24a-25b), dorsal cochlear (DC; Fig 24b-25b)
nuclei, and central gray of the pons (CGPn; Fig 17a-b) were moderately labeled.

HINDBRAIN/CEREBELLUM
Trigeminal nucleus.
The Sp5 (Fig 24b-25b) and Pr5 (Fig 22b-24a) were weakly labeled. The Mo5 (Fig 22bc-23a) was
moderately labeled.
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Raphe nucleus.
There was weak labeling throughout the raphe nuclei (DR, RIP, RLi, RMg, ROb, RPa, CLi, PMnR,
MnR; Fig 21b-25b).

Cerebellum.
Weak signals were identified in the cerebellar cortex (Cb1-10; Fig 23-25a). The interposed
cerebellar (Int), lateral cerebellar (Lat), and medial cerebellar (Med) nuclei were moderately
labeled (24-18a).
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FIGURE 12. Detailed distribution of TMEM35-expressing cells in the striatum, cerebral cortex and nucleus accumbens Serial coronal
sections in male Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 17-22); immunohistochemically
stained images (left) and the abbreviation-tagged images (right); list of abbreviations page 143 and is colored depending on the
expression quantity: high = red; moderate = yellow; low = blue; negative = white. Scale bar: 1 mm.

44

A

B

FIGURE 13. Detailed distribution of TMEM35-expressing cells in the the bed nucleus of stria terminalis, cerebral cortex and septal
region. Serial coronal sections in male Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 17-22);
immunohistochemically stained images (left) and the abbreviation-tagged images (right); list of abbreviations page 143 and is
colored depending on the expression quantity: high = red; moderate = yellow; low = blue; negative = white. Scale bar:1 mm.
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FIGURE 14. Detailed distribution of TMEM35-expressing cells in the bed nucleus of stria terminalis, cerebral cortex, and
diencephalon. Serial coronal sections in male Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 23-26);
immunohistochemically stained images (left) and the abbreviation-tagged images (right); list of abbreviations page 143 and is
colored depending on the expression quantity: high = red; moderate = yellow; low = blue; negative = white. Scale bar: 1mm.
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FIGURE 15. Detailed distribution of TMEM35-expressing cells in the cerebral cortex, hippocampus, amygdala, and diencephalon.
Serial coronal sections in male Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster Fig 27-31);
immunohistochemically stained images (left) and the abbreviation-tagged images (right); list of abbreviations page 143 and is
colored depending on the expression quantity: high = red; moderate= yellow; low= blue; negative= white. Scale bar:1 mm.
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FIGURE 16. Detailed distribution of TMEM35-expressing cells in the cerebral cortex, hippocampus, amygdala, and diencephalon.
Serial coronal sections in male Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 27-31);
immunohistochemically stained images (left) and the abbreviation-tagged images (right); list of abbreviations page 143 and is
colored depending on the expression quantity: high = red; moderate = yellow; low = blue; negative = white. Scale bar:1 mm.
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FIGURE 17. Detailed distribution of TMEM35-expressing cells in the rostral midbrain, mammillary bodies, and adjacent cerebral.
Serial coronal sections in male Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 32-34);
immunohistochemically stained images (left) and the abbreviation-tagged images (right); list of abbreviations page 143 and is
colored depending on the expression quantity: high = red; moderate = yellow; low = blue; negative = white. Scale bar:1 mm.
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FIGURE 18. Detailed distribution of TMEM35-expressing cells in the rostral midbrain, mammillary body, and adjacent cerebral
cortex. Serial coronal sections in male Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 35-36);
immunohistochemically stained images (left) and the abbreviation-tagged images (right); list of abbreviations page 143 and is
colored depending on the expression quantity: high = red; moderate = yellow; low = blue; negative = white. Scale bar:1 mm.
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FIGURE 19. Detailed distribution of TMEM35-expressing cells in the midbrain. Serial coronal sections in male Syrian hamster brains
(A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 37-39); immunohistochemically stained images (left) and the abbreviationtagged images (right); list of abbreviations page 143 and is colored depending on the expression quantity: high = red; moderate =
yellow; low = blue; negative = white. Scale bar: 1 mm.
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FIGURE 20. Detailed distribution of TMEM35-expressing cells in the midbrain. Serial coronal sections in male Syrian hamster brains
(A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 37-39); immunohistochemically stained images (left) and the abbreviationtagged images (right); list of abbreviations page 143 and is colored depending on the expression quantity: high = red; moderate =
yellow; low = blue; negative = white. Scale bar: 1 mm.
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FIGURE 21. Detailed distribution of TMEM35-expressing cells in the midbrain and pons. Serial coronal sections in male Syrian
hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 40-44); immunohistochemically stained images (left) and the
abbreviation-tagged images (right); list of abbreviations page 143 and is colored depending on the expression quantity: high = red;
moderate = yellow; low = blue; negative = white. Scale bar: 1 mm.

53

A

B

FIGURE 22. Detailed distribution of TMEM35-expressing cells in the midbrain and pons. Serial coronal sections in male Syrian
hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 40-44); immunohistochemically stained images (left) and the
abbreviation-tagged images (right); list of abbreviations page 143 and is colored depending on the expression quantity: high = red;
moderate = yellow; low = blue; negative = white. Scale bar: 1 mm.

54

A

B

FIGURE 23. Detailed distribution of TMEM35-expressing cells hindbrain and cerebellum. Serial coronal sections in male Syrian
hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 45-47); immunohistochemically stained images (left) and the
abbreviation-tagged images (right); list of abbreviations page 143 and is colored depending on the expression quantity: high = red;
moderate = yellow; low = blue; negative = white. Scale bar: 1 mm.
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FIGURE 24. Detailed distribution of TMEM35-expressing cells in the hindbrain and cerebellum. Serial coronal sections in male
Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 48-54); immunohistochemically stained images (left)
and the abbreviation-tagged images (right); list of abbreviations page 143and is colored depending on the expression quantity: high
= red; moderate = yellow; low = blue; negative = white. Scale bar: 1 mm.
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FIGURE 25. Detailed distribution of TMEM35-expressing cells in the hindbrain and cerebellum. Serial coronal sections in male
Syrian hamster brains (A,B). (The Stereotaxic Atlas of the Golden Hamster; Fig 48-54); immunohistochemically stained images (left)
and the abbreviation-tagged images (right); list of abbreviations page 143 and is colored depending on the expression quantity: high
= red; moderate = yellow; low = blue; negative = white. Scale bar: 1 mm
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DISCUSSION:
In the present study, we developed a comprehensive map of TMEM35 protein
expression in the central nervous system of male Syrian hamsters. TMEM35 is a highly
conserved transmembrane protein that exists in humans, mice, hamsters, rats, canines, cattle,
chicken, zebra fish, mosquito, frog and Drosophila species (Tran et al., 2010). However, despite
the level of evolutionary conservation across species and previous work done to investigate
TMEM35, the functional role of this protein remains largely unknown. Thus, we believe that
building a brain map based on TMEM35 expression will be helpful for future research in
determining functional roles for this protein within the nervous system.
Our distribution map of TMEM35 protein in the CNS of male Syrian hamsters
determined the expression pattern of TMEM35 to be both localized and widespread
throughout the CNS. Strong expression patterns were observed in several structures such as the
hippocampal formation, hypothalamic areas, limbic areas, thalamic areas, and olfactory areas.
Expression patterns within these areas suggest a potential role for TMEM35 in social behaviors
including, sexual behavior, rewarding behaviors and reproductive behaviors. Numerous other
TMEM35-expressing cell populations were found to have moderate to low expression levels
within the brain.
Weak TMEM35 expression was observed in the cerebellum and the basal ganglia
(claustrum, globus pallidus, and striatum). These brain areas provide clues regarding putative
functions of TMEM35. Several nuclei involved in the auditory pathway were weakly labeled
including, the auditory cortex, medial geniculate body of the thalamus, inferior colliculus,
cochlear, and superior olive nuclei. These findings suggest that TMEM35 might play role in the
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auditory system including, development (Barkat et al., 2011), hormones and behavior (Marlin et
al., 2015; Schneider et al., 2014), and reward-related plasticity (Kato et al., 2015).
TMEM35 was expressed in several nuclei that are involved the neural circuits of anxiety,
including: high cell numbers in the anterior hypothalamic nucleus, basolateral amygdala, bed
nucleus of the stria terminalis, infralimbic division of the prefrontal cortex (PFC), lateral septum,
nucleus accumbens, prelimbic division of the PFC, paraventricular nucleus of the hypothalamus,
paraventricular thalamus, hippocampus, and ventral tegmental area; moderate cell numbers in
the ventral pallidum, motor cortices, and locus coeruleus; and weak cell numbers in the lateral
hypothalamus, central amygdala, somatosensory cortices, periaqueductal gray, and dorsal
raphe nucleus. TMEM35 expression in these areas suggest that this protein may have a function
in emotional behaviors (Calhoon & Tye, 2015). These findings are in agreement with a previous
study that determined TMEM35 role in fear and spatial learning (Kennedy et al., 2016).
Several TMEM35-immunoreactive cells were identified in the coronal sections of the
intact male hamsters. Immunohistochemical and in situ hybridization (ISH) work in rodents
demonstrated that the largest population of TMEM35-positive cells exist within the olfactory,
hippocampal formation, hypothalamic, medulla, and limbic areas. Compared to ISH in mice,
however, immunohistochemistry in hamsters appears to detect fewer overall numbers of
TMEM35 cells. These differences in cell numbers may be due to post-transcriptional regulation
of TMEM35 mRNA. The expression levels of TMEM35 protein may also be due to translational
management, such as translation efficiency, the half-life of the protein, and/or protein damage
or degradation (Silva & Vogel, 2016). The differing expression levels of TMEM35 mRNA and
protein could be a cause of how the protein contributes to cell-specific functions. Finally, the
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differences in numbers could also be due to the species difference, as our study was conducted
in hamsters, and the others used mice as an animal model.
Different aspects of gene expression, such as regulatory processes following mRNA
production, regulate protein levels. However, it cannot be assumed that mRNA quantities are
directly correlated with protein expression levels in mammalian cells, in which the correlation
between mRNA and protein expression levels is lower and much more variable (Silva & Vogel,
2016). Therefore, because small changes in protein expression contribute to defining cellular
functions, is it important to compare mRNA and protein expression. It is also important to note
that although in situ hybridization (ISH) is invaluable in defining the locations of cells that
express mRNA, immunohistochemistry for protein expression can detect not only cells but also
protein-expressing fibers within the brain.
Immunoreactive TMEM35 fibers have been previously reported in the hippocampal
formation, ventromedial hypothalamus and amygdala (Kennedy et al., 2016). We have
identified many additional unreported TMEM35 immunoreactive fibers in the hamster brain.
The great majority of fiber staining was found within the suprachiasmatic nucleus, arcuate
nucleus, supraoptic nucleus, bed nucleus of the stria terminalis, paraventricular hypothalamic
nucleus, dorsomedial hypothalamic nucleus, anteroventral periventricular nucleus,
paraventricular hypothalamic nucleus, medial preoptic nucleus, premammilary nucleus, and
paraventricular thalamic nucleus. These data are consistent with previously reported functions
of TMEM35 localization in the neurites. As previously suggested, TMEM35 localization along the
neurite indicates that the peptide is both released as a neuropeptide and membrane bound in
neurons (Kennedy et al., 2016). The study by Kennedy et al. revealed that TMEM35 is required
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for normal expression of synaptic proteins (N-methyl D-aspartate receptor subtype 2B or
postsynaptic density protein-95) that are critical for synaptic sculpturing and remodeling
(Kennedy et al., 2016). Therefore, TMEM35 may be critical for synaptic sculpting in the fiber of
these newly identified nuclei.
In the present study, our described expression patterns mirrored the previously
described TMEM35 mRNA expression. Our distribution map of TMEM35 protein expression in
the CNS is consistent with previous findings about TMEM35 mRNA expression
(http://mouse.brain-map.org; (Kennedy et al., 2016; Kurrasch et al., 2007). In addition, we
identified several distinct regions and nuclei in which TMEM35 protein was expressed intensely,
such as the anteroventral periventricular nucleus, nucleus accumbens, medial preoptic nucleus,
suprachiasmatic nucleus, supraoptic nucleus, piriform cortex, and paraventricular thalamic
nuclei. These findings and specific identifications provide additional information that
contributes to possible putative functions of TMEM35 protein within the nervous system.
Our data indicate that TMEM35 protein is found in various brain regions, with high
expression within limbic and hypothalamic areas. This is the first comprehensive map of
TMEM35 protein expression within the literature, and we hope that it will help guide future
studies into the functions of this highly conserved peptide. However, this is not the first study
to investigate TMEM35 function, as a study by Kennedy et al. investigated the involvement of
TMEM35 in the context of fear and spatial learning. This work demonstrated that TMEM35knockout mice exhibited elevated basal corticosterone, anxiety-like behavior, impairments in
long-term fear and spatial memories, decreased long-term potentiation, and increased startled
reactivity and locomotion (Kennedy et al., 2016). In addition, Kennedy et al. proposed that
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TMEM35 may have a potential role in the regulation of dendritic spine morphology due to the
presence of a p75 receptor-bind motif in the protein sequence (Kennedy et al., 2016; Tran et
al., 2010; Wiesmann et al., 1999). Lastly, work by Huang et al. suggested a possible role for
TMEM35 in the growth, migration, and cell cycle progression of osteosarcoma cells (Huang et
al., 2016). Furthermore, this study also determined that potential functional partners of
TMEM35 included neuropeptide Y, nerve growth factor, nerve growth factor receptor, brainderived neurotropic factor, calcitonin-related polypeptide β, and vasoactive intestinal peptide,
indicating that TMEM35 is well-situated to be involved in various functions (Huang et al., 2016).
Overall, the identified functions of TMEM35 to date are consistent with previous findings of its
expression in the adrenal glands, hypothalamic areas, and limbic regions (Hawrylycz et al.,
2012; Kennedy et al., 2016; Kurrasch et al., 2007; Tran et al., 2010).
Taken together, we have successfully mirrored previous findings of TMEM35 mRNAexpressing regions with TMEM35 protein regions through observational analysis using
immunohistochemistry of Syrian hamster brains. Our anatomical evidence is of immense value
in developing an understanding of the potential roles of TMEM35 in the mammalian nervous
system.
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CHAPTER THREE: SEXUAL DIMORPHISM IN TMEM35 PROTEIN EXPRESSION
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INTRODUCTION:
The central nervous system (CNS) is different in activity, chemistry, development and
structure in males compared to females. Several animal studies have determined the cause of
sex differences in the CNS to be a product of environmental and biological influences, including
sex chromosomes, prenatal hormones, immune system function, steroid hormone levels, and
sex-based gene expression (Ruigrok et al., 2014). The mechanisms that underlie these sex
differences are still unclear, specifically those involved in controlling sex-specific behaviors and
brain function.
The functions of several key molecules, such as cyclic adenosine monophosphate
response-element binding protein (CREB), kisspeptin, delta FosB, and brain-derived
neurotrophic factor (BDNF), have been shown to act in a sexually dimporphic manner by a
number of previous studies (Chan & Ye, 2017; Edwards et al., 2007; V. L. Hedges et al., 2009; Lu
et al., 2004). These sex differences could be due to the modulating effects of gonadal sex
steroids: androgens in males, and estrogen/progesterone in females. Further, in addition to the
effects of sex steroid hormones, neuropeptides are important chemical messengers that
mediate a variety of motivational, cognitive, and emotional functions that have been
determined to be under sex steroid modulation (Bos et al., 2012; Calley & Dhillo, 2014; Smith et
al., 2005). Neuropeptides are small proteins produced and released by neurons that act on
neural substrates (neurons, glial cells, etc.) (Burbach, 2011).
A novel neuropeptide, transmembrane protein 35 (TMEM35) protein is conservatively
expressed across species and is thought to modulate signaling in the central nervous system
(CNS) (Kennedy et al., 2016; Tran et al., 2010). The functions of TMEM35 are not fully
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understood and are poorly studied, with only three publications in the literature (Huang et al.,
2016; Kennedy et al., 2016; Tran et al., 2010). Studies performed by our laboratory (chapter
two) and Kennedy et al. (2016) have identified TMEM35 protein and mRNA expression in both
hypothalamic and limbic regions of the brain (Kennedy et al., 2016). Due to the known
functions of these two regions, this pattern of expression indicates possible roles of this
neuropeptide in social behavior and reward. Interestingly, TMEM35 mRNA exhibits possible
sexual dimorphisms in rodents in that the overall expression of TMEM35 mRNA is higher in
females than in males (Kennedy et al., 2016). However, this qualitative evaluation of sex
differences in mRNA expression has not been quantitatively described throughout the brains of
male and female rodents. Indeed, limited research has been dedicated to directly investigating
sex differences between males and females in various brain circuits involved in behavior. The
implicated sexual dimorphisms combined with previous work from our laboratory identifying
TMEM35 protein expression throughout limbic and hypothalamic regions led us to directly
investigate whether TMEM35 protein expression is sexually dimorphic in expression within the
brain.
To this end, we used a Syrian hamster model system to investigate the putative sex
difference in brain expression of the TMEM35 protein through identification of immunepositive cells in both females and males. We determined the proportion of TMEM35-expressing
cells in several brain areas to directly assess differences in protein expression between males
and females. Identifying biological sex differences in TMEM35 expression will help develop a
better understanding of the potential function of this highly conserved neuropeptide.
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METHODS:
Animals:
A total of 13 gonadally intact Syrian hamsters (Mesocricetus auratas), 6 female and 7
male, were used at 50-80 days of age in this study. The same 7 male animals that were used to
map TMEM35 expression throughout the brain in chapter two of this thesis were also used for
the following study. Females were generated through an IACUC- approved hamster breeding
colony and housed individually in plastic cages (10.2 in x 18.7 in x 8.2 in). All hamsters were
given ad libitum access to food and water. Temperature in the animal room was maintained at
a controlled 22oC with a 14:10 hour light-dark schedule (lights off between 1 and 11 p.m.). All
procedures in this experiment were used in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals and were approved by the Northern
Michigan University Institutional Animal Care and Use Committee.

Tissue Processing:
For brain tissue immunostaining, animals were transcardially perfused with cold 25mM
PBS and 4% paraformaldehyde, as previously described (Chapter 2). Brain tissue was post-fixed
with 4% paraformaldehyde for 2-3 hours and cryoprotected in a 10 % sucrose solution. Using a
Leica CM1850 cryostat, the entire brain was frozen and tissue was serially sectioned at 40-μm
in a coronal orientation, and collected alternatively in two separate six-well plates containing
25mM phosphate buffered saline + 0.1% bovine serum albumin (wash buffer).
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Nissl Staining:
One plate of free-floating sections was rinsed three times (10 minutes each) in wash
buffer, immediately mounted on Adhesion Superfrost Plus slides (Brain Research Labs, Waban,
MA, USA), and allowed to dry overnight at room temperature. After the sections were dried,
they were stained for Nissl bodies in the cytoplasm of neurons using a cresyl violet acetate
solution (1.0% (w/v), Sigma-Aldrich, St. Louis, MO, USA), dehydrated in a graded ethanol series,
cleared in CitriSolv (Fisher Scientific), and cover-slipped using DPX (Sigma-Aldrich Chemicals, St.
Louis, MO, USA) as previously described in chapter two.

Immunohistochemistry:
According to the method used in chapter two, immunohistochemical staining for
TMEM35 was performed using the primary antibody, rabbit anti-TMEM35152-167 (1: 4500, gift
from Dr. Phu Tran) in a 48-hour incubation. Following washing with wash buffer (3x), the tissues
was incubated with a secondary biotinylated-goat anti-rabbit IgG antibody (1:200, Vector
Laboratories) for 45 minutes and an avidin-biotin horseradish peroxidase complex (1:50, Vector
Laboratories) for 45 minutes. The brain tissue was given appropriate rinses in wash buffer and
Tris buffer (7.45 grams Trizma pre-set crystals/L dd H2O). The tissue was stained with 2mM 3, 3’
diaminobenzidine (DAB) solution for five minutes. Sections were put through a final series of
washes to stop the chromagen reaction, one 10-minute wash in Tris buffer and two 10-minute
washes in deionized water. Sections were mounted on Adhesion Superfrost Plus slides (Brain
Research Labs, Waban, MA), left to dry overnight and finally were dehydrated, cleared, and
cover-slipped as described in chapter two.
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Imaging and Data Collection:
Images were collected using an Olympus BX41 light microscope coupled to an Olympus
DP72 digital camera using a 10x objective. High expression areas of positive cells were analyzed
and counted. Images were prepared by placing counting boxes over images using Photoshop
(Adobe Systems, New York, NY, USA). Cell counts were done manually using ImageJ software
for cresyl violet and TMEM35-labeled tissue. Statistical analyses (t-test) were performed
(GraphPad Prism software), to determine statistical significance between males and females in
the number of TMEM35-expressing cells and for the proportion on neurons expressing
TMEM35 to cresyl violet-labeled tissue.
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RESULTS:
Distribution of TMEM35-immunoreactive cell bodies in male and female Syrian Hamster central
nervous systems
In the brain of Syrian hamsters, the distribution of TMEM35-expressing cell bodies in
females was similar to previous work in our laboratory (in males), as well as to that of other
previous studies (Kennedy et al., 2016; Kurrasch et al., 2007). The immunohistochemical
detection of TMEM35 using the rabbit TMEM35152-167 antibody labeled TMEM35-expressing
cells throughout the CNS of both males and females. Intensely labeled cell bodies were
scattered throughout the rostro-caudal hypothalamic and limbic regions of the Syrian brain (Fig
26)
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Figure 26. Topographic distribution of TMEM35-immunoreactive cells in representative coronal section of male and female Syrian
hamster CNS (top (A) and bottom (B) panels, respectively). 3V, 3rd ventricle; ARC, actuate nucleus; BLA, basolateral amygdala; cc,
corpus callosum; CM, central medial thalamic nucleus; D3V, dorsal 3rd ventricle; DMH, dorsomedial hypothalamus; Hb, habenular
nucleus; HIPP; hippocampal formation; ic, internal capsule; MA, medial amygdala; ot, optic tract; PVP, paraventricular thalamic
nucleus; Rt, reticular formation; VMH, ventromedial hypothalamus. Scale bar: 1mm
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Sexual dimorphism of TMEM35 protein expression in CNS of Syrian Hamsters
To assess potential dimorphism in TMEM35 protein expression in males, we focused on
44 specific brain regions where TMEM35 protein was highly expressed (Chapter 2, Fig 8-14). To
characterize sex differences in protein expression, we used immunohistochemistry to identify
TMEM35-positive cells in the brains of intact male (n=7) and female (n=6) Syrian hamsters.
Male and female cell counts in individual nuclei were directly compared and analyzed using a ttest. Table 2 is a comprehensive list of the 44 specific brain regions that were investigated.
There was a visible difference in the extension of immunoreactivity of TMEM35-positive
cell bodies with intact females vs. intact males. The previously described qualitative differences
were confirmed by the present quantitative analysis showing significant sex differences for
several examined nuclei. TMEM35152-167 staining in males revealed consistently fewer
immunoreactive cells in the anterior hypothalamic nucleus (AH), anteroventral periventricular
nucleus (AVPV), bed nucleus of the stria terminalis (BNST), dorsomedial hypothalamus (DMH),
dorsal lateral septum (LSd), dorsal medial amygdala (MAd), medial caudate (MCU), medial
preoptic nucleus (MPN), nucleus accumbens core (NAcc), nucleus accumbens shell (NAcsh),
suprachiasmatic nucleus (SCN), and ventromedial hypothalamus (VMH) compared with
TMEM35 expression in females (right and left panels in Fig 27-35, respectively; Fig 31). This
difference was particularly evident for the AVPV (p < 0.01 t=3.819 Fig 27), BNST (p < 0.01,
t=3.347; Fig 27), NAcc (p < 0.01, t=3.362; Fig 29), SCN (p < 0.01, t=3.588; Fig 30), and VMH (p <
0.0001, t=6.887; Fig 30).
We compared the proportion of cell counts between cresyl violet (CV)-stained images
(detecting total neuron count) and TMEM35-stained images (Fig 32-35). This allowed us to
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reliably localize and map labeled cell populations in the brain. It also allowed us to compare
overall all neuronal counts (CV) to TMEM35-positive cell counts in previously reported sexually
dimorphic nuclei (Fig 36).
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Table 2. Comprehensive list of the studied brain regions in male and female Syrian hamsters. The addition symbol signifies
TMEM35 protein expression. The supplementary addition symbols in the female column indicate a significance difference in
TMEM35 cell counts when compared to males, ++P < 0.05; +++P < 0.01; ++++P < 0.0001

Brain Region
ACO
AD
AH
AHI
ARC
AVPV
BLA
BNST
CA1
CA2
CA3
CL
CM
DEN
DGd
DGv
DMH
HB
LA
LCU
LH
LSd
LSv
MAd
MAv
MCU
MPN
MPO
MNPO
NAcc
NAcsh
NBD
OVLT
PFC
PIR
PMV
PVN
PVP
SCN
SON
SUM
VTA
VP
VMH

Males
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

Females
+
+
++
+
+
+++
+
+++
+
+
+
+
+
+
+
+
++
+
+
+
+
++
+
++
+
++
++
+
+
+++
++
+
+
+
+
+
+
+
+++
+
+
+
+
++++
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Figure 27. Representative images of male and female TMEM35-immunoreactive neuronal cell bodies in the anterior
hypothalamus, anteroventral periventricular nucleus, and bed nucleus of the stria terminalis of male and female Syrian hamster
brains (right and left panels, respectively). 10x photomicrographs showing TMEM35 immunoreactivity in anterior hypothalamus
(A,B); anteroventral periventricular nucleus (C,D); bed nucleus of the stria terminalis (E,F). 3V, 3 rd ventricle; f, fornix; LV, left ventricle;
ox, optic chiasm. Scale bar: 1mm.
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Figure 28. Representative images of male and female TMEM35-immunoreactive cells in the dorsal medial hypothalamus, medial
amygdala, and medial caudate of male and female Syrian hamster brains (right and left panels, respectively). 10x
photomicrographs showing TMEM35 immunoreactivity in dorsomedial hypothalamus (A,B); dorsal medial amygdala (C,D); medial
caudate (E,F). cc, corpus callosum; MAd, dorsal medial amygdala; MAv, ventral medial amygdala; ox, optic chiasm; LV, left ventricle.
Scale bar: 1mm.
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Figure 29. Representative images of male and female TMEM35-immunoreactive neuronal cell bodies in the lateral septum, medial
preoptic nucleus, and nucleus accumbens core of male and female Syrian hamster brains (right and left panels, respectively). 10x
photomicrographs showing TMEM35 immunoreactivity in dorsal lateral septum (A,B); medial preoptic nucleus (C,D); nucleus
accumbens core (E,F). 3V, 3rd ventricle; cc, corpus callosum; RV, right ventricle. Scale bar: 1mm.
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Figure 30. Representative images of male and female TMEM35-immunoreactive neuronal cell bodies in the nucleus accumbens
shell, suprachiasmatic nucleus and ventromedial hypothalamic nucleus of male and female Syrian hamster brains (right and left
panels, respectively). 10x photomicrographs showing TMEM35 immunoreactivity in nucleus accumbens shell (A,B); suprachiasmatic
nucleus (C,D); ventromedial hypothalamus (E,F). 3V, 3rd ventricle; shell; ox, optic chiasm. Scale bar: 1mm.
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Figure 31. Quantitative analysis of TMEM35-expressing nuclei in Syrian hamster CNS. Histograms representing the TMEM35positive cell counts in the anterior hypothalamic nucleus (AH), anteroventral periventricular nucleus (AVPV), bed nucleus of the stria
terminalis (BNST), dorsomedial hypothalamus (DMH), dorsal lateral septum (LSd), dorsal medial amygdala (MAd), medial caudate
(MCU), medial preoptic nucleus (MPN), nucleus accumbens core (NAcc), nucleus accumbens shell (NAcsh), suprachiasmatic nucleus
(SCN), and ventromedial hypothalamus (VMH) of male (n=7, white bars) and female (n=6, black bars) Syrian hamsters. *P < 0.05.
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Figure 32. Comparative representations of anteroventral periventricular nucleus of males and females with cresyl violet and
immunohistochemically stained tissue. Photomicrographs (10x) showing TMEM35 immunoreactivity in the anteroventral
periventricular nucleus (AVPV) of males and females (A,B; respectively); 10x photomicrographs showing the AVPV stained with cresyl
violet to determine the overall neuron count in males and females (E,F; respectively). 3V, 3 rd ventricle. Scale bar: 1mm.
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Figure 33. Comparative representations of bed nucleus of the stria terminalis of males and females with cresyl violet and
immunohistochemically stained tissue. Photomicrographs (10x) showing TMEM35 immunoreactivity in the bed nucleus of the stria
terminalis (BNST) of males and females (A,B; respectively); 10x photomicrographs showing the BNST stained with cresyl violet to
determine the overall neuron count in males and females (E,F; respectively). f, fornix; LV, left ventricle. Scale bar: 1mm.
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Figure 34. Comparative representations of medial preoptic nucleus of males and females with cresyl violet and
immunohistochemically stained tissue. Photomicrographs (10x) showing TMEM35 immunoreactivity in the medial preoptic nucleus
(MPN) of males and females (A,B; respectively); 10x photomicrographs showing the MPN stained with cresyl violet to determine the
overall neuron count in males and females (E,F; respectively). 3V, 3rd ventricle. Scale bar: 1mm.
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Figure 35. Comparative representations of ventromedial hypothalamic nucleus of males and females with cresyl violet and
immunohistochemically stained tissue. Photomicrographs (10x) showing TMEM35 immunoreactivity in the ventromedial
hypothalamus (VMH) of males and females (A,B; respectively); 10x photomicrographs showing the VMH stained with cresyl violet to
determine the overall neuron count in males and females (E,F; respectively). 3V, 3rd ventricle. Scale bar: 1mm.
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Figure 36. Quantitative analysis of TMEM35-expressing cells in proportion to Cresyl violet in Syrian hamster CNS. Histograms
representing the TMEM35-positive cell counts in proportion to cresyl violet neurons counts in the (AH), anteroventral periventricular
nucleus (AVPV), bed nucleus of the stria terminalis (BNST), central medial thalamic nucleus (CM), dorsomedial hypothalamus (DMH),
medial preoptic nucleus (MPN), nucleus accumbens core (NAcc), nucleus accumbens shell (NAcsh), piriform cortex (PIR), and
ventromedial hypothalamus (VMH) of male (n=7, white bars) and female (n=6, black bars) Syrian hamsters. *P < 0.05.
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DISCUSSION:
This study represents the first investigation performed in Syrian hamsters directly
comparing TMEM35 expression patterns between intact males and females. Currently,
TMEM35 has a largely unknown function in our nervous system and is insufficiently studied. A
study by Kennedy et al. (2016) indicated that TMEM35 has differing mRNA expression between
males and females in various brain regions (Kennedy et al., 2016).
Whereas overall distribution of TMEM35 was similar between males and females, this
study confirms the presence of a strong dimorphism (more TMEM35-positive cells in females
than in males) in brain regions involved in social behavior (medial preoptic nucleus, anterior
hypothalamus, ventromedial hypothalamus) and in motivated/rewarding behaviors (nucleus
accumbens shell and core, medial caudate), as well as brain regions involved in both systems
(lateral septum, bed nucleus of the stria terminalis, medial amygdala). Furthermore, in females,
there was an increase in TMEM35 protein expression in several brain areas involved in the
hypothalamic –pituitary-gonadal axis (anteroventral periventricular nucleus, medial preoptic
nucleus, ventromedial and dorsomedial nuclei of the hypothalamus, suprachiasmatic nucleus,
hypothalamic paraventricular nuclei). Our data provide evidence that suggests this
neuropeptide has a role in physiological and behavioral systems, including social behavior,
reproductive behavior, and motivated/rewarding behavior. Moreover, the observation that
TMEM35-expressing cells are localized in regions with abundant sex steroid receptors suggests
that this neuropeptide is sensitive to sex steroids.
The hypothalamus contains several sexually dimorphic nuclei that have functional roles
in modulating physiological responses to environmental cues and reproductive behaviors in
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males and females. Several dimorphic hypothalamic nuclei are a part of the hypothalamic –
pituitary-gonadal (HPG) axis. The HPG axis has extensive connections to gonadotropin-releasing
hormone-1 neurons (GnRH), which are a central neuroendocrine regulator of reproduction
(Schwanzel-Fukuda et al., 1989). One dimorphic nuclei in the hypothalamus is the AVPV. The
pattern expression of TMEM35 in the AVPV mirrors the sexual dimorphic nature of this region,
where females express larger neurochemically defined neuronal populations is not uncommon
(Simerly, 2002). There are multiple cell types in the AVPV, including dopamine neurons,
glutamatergic neurons, GABAergic neurons, and kisspeptin-expressing neurons (Lenz et al.,
2012; Ottem et al., 2004), many of which are sexually dimorphic with abundant sex-steroid
receptors, making these regions a major target for sex steroid actions (Panzica & Melcangi,
2016; Smith et al., 2005; Smith et al., 2006). Furthermore, in females, the AVPV is essential in
the initiation of the luteinizing hormone (LH) surge and ovulation and receives extensive
projections from the suprachiasmatic nucleus.
The suprachiasmatic nucleus (SCN) is another nucleus that expressed dimorphism in
TMEM35 expression. Sex differences have been previously reported in the SCN of female
rodents, who have greater numbers of cells containing estradiol receptors  and  (Vida et al.,
2008). The SCN is the master circadian pacemaker that regulates reproductive neuroendocrine
events through direct and indirect signaling to GnRH neurons. The circadian system regulates
the duration of the female estrous cycle. In rodents, this cycle is normally four days, with a
surge in estradiol levels followed by a surge in progesterone. Notably, studies have shown that
lesions to the SCN abolish estrous cycling and the daily surge of gonadotropins (Brown-Grant &
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Raisman, 1977; Gray et al., 1978). In addition to having pronounced projections to the AVPV in
this circuitry, the SCN also sends extensive projections to the dorsomedial hypothalamus.
The dorsomedial hypothalamus (DMH) plays a diverse role in the regulation of
neuroendocrine circuitries (Hunt et al., 2010). A study by Kreigsfeld demonstrated a cluster of
GnRH cells in the DMH of rodents, all of which contain sex steroid receptors and have
widespread projections to hypothalamic and limbic regions. These results suggested that the
DMH plays a role in regulating reproductive and motivated behaviors (Kriegsfeld et al., 2006).
Our study found that the DMH expressed significantly more TMEM35-positive cells in females
compared to males.
Markedly, the medial preoptic nucleus (MPN), bed nuclei of the stria terminalis (BNST),
and medial amygdala (MA), all of which have a great number of neurons and are larger in
volume in males than females, demonstrated a pattern of dimorphism in TMEM35 expression
as well. Although males are known to have more neurons in these regions, females have more
estrogen receptors and thus increased estrogen binding in the MPN (Reddy et al., 2014). The
functional significance of the sexual dimorphism in TMEM35 expression is not known, but these
nuclei are known to modulate different aspects of female sexual behavior including
chemosensory-driven sexual behavior (MA), appropriate targeting of sexual solicitation (BNST),
and copulatory behavior (MPN) (DiBenedictis et al., 2014; Kondo & Sakuma, 2005; Martinez &
Petrulis, 2011, 2013; Xiao et al., 2005). Additionally, these areas are a part of a social behavior
network, which is a subset of limbic system nuclei that plays a role in regulating social behavior,
that consists of six interconnected regions: the MA, BNST, AH, MPN, VMH, LS and
periaqueductal gray/central gray (Newman, 1999; O’Connell & Hofmann, 2011). This network
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expresses abundant sex steroid receptors across a wide range of species. Recent studies
confirm that these circulating steroids are a key mediator of social behaviors in response to
sensory cues (Dey et al., 2015; Gandelman, 1984). Moreover, the anterior hypothalamus (AH),
ventromedial hypothalamus (VMH), and lateral septum (LS) all exhibited dimorphisms in
TMEM35 labeling. The expression of TMEM35 in the VMH mirrors the well-documented sex
differences in several neurochemical markers and sex-specific estrogen responsiveness (Loretta
M. Flanagan-Cato, 2011; Xu et al., 2012). The VMH has a well-established function in female
sexual behavior (Cohen & Pfaff, 1992; Flanagan-Cato, 2011; Jeffrey D Blaustein, 2002; Malsbury
et al., 1977; Meisel & Mullins, 2006). The AH has an implicated role in aggression, parental care,
and sexual behavior, specifically in context of sex steroid and neuropeptide modulation (Bridges
et al., 1999; Ferris & Potegal, 1988; Hayden-Hixson & Ferris, 1991). The lateral septum receives
projections from the AH, MPN, ventral tegmental area, and VMH. Research has implicated a
role for the LS in mediating social behavior and evaluation of stimulus novelty (O’Connell &
Hofmann, 2011). The potential for sexual dimorphism in the periaqueductal gray/central gray
was not examined in this study. The social behavioral network and other systems, such as the
mesolimbic dopamine (ML-DA) system are functionally linked. For example, the preoptic area
has projections to the ML-DA, which regulates motivation for sex and its rewarding properties
for both sexes (Lenz et al., 2012).
Our analysis also showed TMEM35 protein dimorphisms in nuclei in the ML-DA system,
which mediates motivation and reward. The medial caudate (MCU) is a portion of the striatum
that receives massive inputs of dopaminergic projections from the midbrain. The MCU is also
larger in volume in females compared to males (Karaismailoğlu & Erdem, 2013). Sex differences
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have been previously reported in the nucleus accumbens (NAc); in females, there is a greater
density of dendritic spines on medium spiny neurons and activity is enhanced and modulated
by estradiol via the dopaminergic response in the NAc (Becker, 2016).
In this study, while we utilized intact male and female Syrian hamsters, we did not
identify or track which phase of the estrous cycle each female was in at the time of brain
harvest. Previous work has shown that the estrous cycle has phase-dependent effects on
neuropeptides such as NPY, kisspeptin, and BDNF (Marraudino et al., 2017; Martini et al., 2011;
Zhu, et al., 2013). Each phase of the cycle also produces a slight difference in behavior. Our
results could potentially be diluted in that only 12 of the 44 brain regions analyzed showed a
significant difference in TMEM35-positive cell numbers with females expressing higher levels
compared to males. Considering this, there is a possibility for potential sexual differences in
TMEM35 protein expression in other brain areas depending on the phase of estrus. Future
studies are needed to determine the effects of each individual phase of estrus on TMEM35
protein expression.
Due to the sex-specific expression of TMEM35 protein, we hypothesized that TMEM35
potentially induces different functions in different sexes. Further, given that females have
significantly more TMEM35 immunoreactivity in several hypothalamic and limbic regions, it
could also be postulated that female sex steroids may have modulatory effects on TMEM35
mRNA and protein expression patterns. There is limited research dedicated to directly
investigating sex differences between males and females. Sex difference research is crucial in
understanding how the basic biology of the brain differs between males and females.
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CHAPTER FOUR: THE EFFECT OF OVARIAN HORMONES ON TMEM35 PROTEIN EXPRESSION IN
FEMALE SYRIAN HAMSTERS
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INTRODUCTION:
TMEM35 is a protein that is encoded by the transmembrane 35 gene, located on the
human X-chromosome at position Xq22.1 (Huang et al., 2016) and has a molecular weight of 18
kDa (Kennedy et al., 2016; Tran et al., 2010). Furthermore, TMEM35 expression highly
conserved across species; yet, the function of this protein remains poorly understood. Previous
studies have suggested potential roles of TMEM35 in adrenal glomerulosa growth, normal
activity of the hypothalamic-pituitary-adrenal axis and limbic circuitry, and osterosarcoma cell
growth and migration (Huang et al., 2016; Kennedy et al., 2016; Tran et al., 2010). High
expression of both TMEM35 mRNA and protein expressing cells has been described in both the
ventromedial hypothalamus and limbic circuit of both mice and hamsters, positioning TMEM35
to function in female sexual behavior and reward processing.
Previous work in our laboratory determined that several nuclei within the hypothalamus
and limbic regions of the Syrian hamster brain were found to contain TMEM35-immunoreactive
cells. Work in our laboratory also indicated that TMEM35 is sexually dimorphic, with females
expressing higher levels than males in several brain areas, including in the anterior
hypothalamic nucleus (AH), anteroventral periventricular nucleus (AVPV), bed nucleus of the
stria terminalis (BNST), dorsomedial hypothalamus (DMH), dorsal lateral septum (LSd), dorsal
medial amygdala (MAd), medial caudate (MCU), medial preoptic nucleus (MPN), nucleus
accumbens core (NAcc), nucleus accumbens shell (NAcsh), suprachiasmatic nucleus (SCN), and
ventromedial hypothalamus (VMH). Many of these TMEM35-reactive nuclei are sexually
dimorphic, functioning in regulating physiological responses to stimuli and reproductive
behaviors in both sexes. These nuclei are also known to be sensitive to gonadal hormones,
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which have been shown to modulate sex specific behaviors. The observed sex difference in
TMEM35 expression within the social behavioral network, mesolimbic reward system, and
regions that control reproductive behavior suggest a functional role for this protein in
motivated/rewarding behaviors, social behavior, and reproductive behavior.
The mesolimbic reward system and social behavioral network constitutes several limbic
and hypothalamic nuclei that work in concert to modulate rewards and social behaviors, such
as sexual behavior, aggression, and parental behavior (Newman, 1999). Additionally, several of
these nuclei are also involved in the hypothalamic–pituitary-gonadal (HPG) axis, which has
extensive connections to gonadotropin-releasing hormone-1 neurons. The HPG axis is a central
regulator of reproduction and social behaviors (i.e. sexual behavior) (Schwanzel-Fukuda et al.,
1989). Together, these circuits/networks are reciprocally connected and contain a great
number of sex steroid hormone receptors (Newman, 1999).
Reproductive steroids (androgens in males and estrogen and progestin in females) play
fundamental roles in the development and function of the central nervous system. Gonadal
hormones elicit effects by binding to distinct receptors in localized brain regions to influence
physiology and behavior (Mangelsdorf et al., 1995; Tetel, 2009). Further, these hormones act
via both organizational and activational mechanisms to alter nervous system anatomy and
physiology. Organizational effects permanently and irreversibly organize the nervous system
during development (Elekonich & E. Robinson, 2000). In adulthood, the same steroids have
activational effects, which activate, modulate and inhibit behaviors in response to social or
environmental conditions (Elekonich & E. Robinson, 2000). Ovarian hormones (estrogen and
progestin) have been extensively studied and are implicated in a variety of nervous system

91

functions, including development, growth, cognition and behavior. Estrogen and progestin act
in defined neuronal populations in males and females that are essential for sex-typical displays
in behavior (Baudry et al., 2013; Becker, 2005; Petersen et al., 2013).
Due to the anatomical distribution patterns of TMEM35 in hypothalamic and limbic
regions of the rodent brain, coupled with the known functions of these structures, we
hypothesized that ovarian hormones have modulatory effects on TMEM35 expression patterns
in female Syrian hamsters. To determine this, we ovariectomized adult female Syrian hamsters
to remove the major endogenous source of gonadal steroid hormones, and primed them with
estradiol and progesterone to mimic the natural hormonal cycle or with a cottonseed oil vehicle
as a control. We immunohistochemically stained for TMEM35-expressing cells after giving
behaviorally effective doses of steroid hormones or cottonseed oil vehicle. Furthermore, we
focused on hypothalamic and limbic brain areas that were previously identified as displaying a
sex difference in TMEM35 protein expression to determine if TMEM35 expression in these
same areas were reactive to ovarian hormones.

METHODS:
Animals:
Female Syrian hamsters (Mesocricetus auratas) (n=18, 80-140 days of age) were
generated through a Northern Michigan University IACUC-approved hamster-breeding colony.
Animals were housed at a controlled temperature (22oC) and fed standard rodent pellets and
water ad libitum. Animals were housed individually in plastic cages (10.2 in x 18.7 in x 8.2 in).
The colony room was maintained on a reversed 14-hour light-dark cycle (lights off between 1
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and 11 p.m.). All procedures used were approved by the Institutional Animal Care and Use
committee at Northern Michigan University and in accordance with NIH guide for the Care and
Use of Laboratory Animals.

Surgery:
Female hamsters were bilaterally ovariectomized (OVX) (surgical removal of the ovaries)
to remove the source of endogenous ovarian hormones. One hour prior to surgery, animals
were given an analgesic, meloxicam (0.5mg/kg PO). The surgery was performed aseptically
under 2% Isoflourane (Henry Schein Animal Health) anesthesia vaporized in 100% oxygen. After
the animal was unresponsive to a mild noxious stimulus (toe pinch), a small dorsal incision was
made in the skin and muscle layers near the junction of the last rib and the vertebral column.
The ovary, in a fat pad lying directly under the muscles, was lifted through the incision, clamped
with a hemostat, tied off with absorbable suture, and cut off with a scalpel. The muscle layers
were sutured with synthetic absorbable sutures, and the skin was closed with wound clips. This
procedure was performed bilaterally. During surgery, eye lubricant was placed on the eyes, due
to the inhibition of the blink reflex by anesthetic administration. An additional dose of
Meloxicam (0.5mg/kg PO) was administered 24 hours after the initial dose. OVX females were
allowed to recover for one week prior to experimental testing.

Hormone/Oil Injections:
Ten OVX females were given ovarian hormone injections to mimic their natural estrous
cycle. Subcutaneous injections of estradiol benzoate (10 g in 0.1 mL of cottonseed oil) were
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administered approximately 48 hours and again 24 hours prior to tissue harvest, followed by a
subcutaneous injection of progesterone (500 g in 0.1 mL cottonseed oil) 4-6 hours prior to
tissue harvest. A control group of eight OVX females was given subcutaneous injections of
cottonseed oil vehicle (CSO-vehicle, 0.1 mL) approximately 48 hours and 24 hours prior to
tissue harvest, followed by another injection of cottonseed oil (0.1 mL) 4-6 hours prior to tissue
harvest. Four hours following the last cottonseed oil or progesterone injections, hamsters were
deeply anesthetized and intracardially perfused. Intracardial perfusions were performed as
previously described in chapter two. Brains were removed and post fixed for 2-3 hours, and
cryoprotected in 10% sucrose at 4 C overnight. 40-μm coronal sections were serially cut using
a Leica CM1850 Cryostat and collected into a six- well plate containing 25mM PBS + 0.1%
bovine serum albumin (BSA) (wash buffer).

Immunohistochemistry:
Free-floating sections were rinsed (3x for 10 min) in wash buffer. Primary antibody
incubation was carried out at room temperature (RT) in wash buffer containing 0.03% Triton-X100, and rabbit anti-TMEM35152-167 (1: 4500, gift from Dr. Phu Tran, University of Minnesota)
for ~24 hours and then ~24 at 4oC. After washing in wash buffer (3x for 10 min), sections were
incubated in a biotinylated-goat anti-rabbit IgG secondary (1:200, Vector Laboratories) diluted
in wash buffer for 45 minutes at RT. After washings, sections were incubated for an additional
45 minutes at RT in an avidin-biotin horseradish peroxidase complex in wash buffer (1:50,
Vector Laboratories). Sections were rinsed in wash buffer and Tris buffer (pH 7.6) for 10
minutes each. The tissue was reacted with 2mM 3, 3’ diaminobenzidine (DAB) and 0.003%
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hydrogen peroxide in Tris for five minutes. Sections were put through a series of three more 10
minute rinses (One rinse in Tris and two in deionized water) to stop the chromagen reaction.
Sections were mounted on Adhesion Superfrost Plus slides (Brain Research Labs), cleared, and
cover-slipped using DPX (Sigma-Aldrich Chemicals).

Imaging and Data Collection:
Images were collected using an Olympus BX41 light microscope coupled to an Olympus
DP72 digital camera using a 10x objective. Areas that were previously identified as sexually
dimorphic were counted and analyzed, including the AH, AVPV, BNST, DMH, LSd, MAd, MCU,
MPN, NAcc, NAcsh, SCN, and VMH. The paraventricular hypothalamic nuclei and the CA1 and
CA2 of the hippocampus were also analyzed because of the previously reported effects ovarian
hormones elicit within these regions. Images were prepared by using Photoshop (Adobe
Systems) to place counting boxes over images. Cells counts were done manually using ImageJ
software for TMEM35-labeled tissue. A t-test statistical analysis was performed using GraphPad
Prism software to determine significance between CSO-vehicle and hormone-treated females in
the number of TMEM35 expressing cells.
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RESULTS:
Distribution of TMEM35-immunoreactive cell bodies in the CNS of female Syrian hamsters
In the brains of hormone-treated and CSO-treated female Syrian hamsters, the
distribution of TMEM35 positive cell bodies was in agreement to previous work in our
laboratory and to other previous reports (Kennedy et al., 2016; Kurrasch et al., 2007). The
immunohistochemical detection of TMEM35 was visualized in hypothalamic and limbic areas of
both CSO- and hormone-treated female Syrian hamsters (Fig 37a-b).

Effects of ovarian hormones on TMEM35 protein expression
As demonstrated in chapter 3 (Figure 26), sexually dimorphic TMEM35 proteinexpressing neurons were concentrated within several limbic and hypothalamic structures of
intact Syrian hamsters. A total of 15 brain areas were investigated in this study (Table 3). The
current study revealed a marked increase in the number of TMEM35-expressing neurons in the
OVX hormone-treated group (n=10) compared to the OVX CSO-treated group (n=8) (Fig 30-35).
Specifically, in the anterior hypothalamus (p < 0.01, t=3.108; Fig 38 A,B), CA1 of the
hippocampal formation (p < 0.001, t=5.213; Fig 38 C,D), dorsal medial amygdala (p < 0.05,
t=2.57; Fig 39 A,B), medial caudate (p < 0.05, t=2.668; Fig 39 D,C), nucleus accumbens shell (p <
0.05, t=2.632; Fig 40 A,B), paraventricular hypothalamic nucleus (p < 0.001, t=4.259; Fig 41 A,D),
and the medial portion of the ventromedial hypothalamus (p < 0.01, t=3.277; Fig 41 C,D). The
lateral portion of the ventromedial hypothalamus (Fig 41 C,D) showed trends with p-value=
0.0657, t=2.009.
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CSO

E2+P

Figure 37.a. Topographic distribution of TMEM35-immunoreactive cells in representative coronal sections of CSO and E+P-treated female Syrian hamster CNS (left (A,C) and right
(B,D) panels, respectively). 3V, 3rd ventricle; ac, anterior commissure; AVPV, anteroventral periventricular nucleus; BNST, bed nucleus of the stria terminalis; cc, corpus callosum; f,
fornix; LS, lateral septum; LV, left ventricle; MA, medial amygdala; MCU, medial caudate; NAcc, nucleus accumbens core; NAcsh, nucleus accumbens shell; ot, optic tract; ox, optic
chiasm; Pir, piriform cortex. Scale bar: 1mm.
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CSO

E2+P

Figure 37.b. Topographic distribution of TMEM35-immunoreactive cells in representative coronal sections of CSO and E+P-treated female Syrian hamster CNS (left (A,C) and right
(B,D) panels, respectively). 3V, 3rd ventricle; AH, anterior hypothalamus; ARC, arcuate nucleus; cc, corpus callosum; CM, central medial thalamic nucleus; D3V, dorsal 3rd ventricle;
DMH, dorsomedial hypothalamus; Hb, habenular nucleus; HIPP, hippocampal formation; LV, left ventricle; MA, medial amygdala; ot, optic tract; ox, optic chiasm; Pir, piriform
cortex; PVN, paraventicular hypothalamic nucleus. PVP, paraventricular thalamic nucleus; SCN, suprachiasmatic nucleus; SON, supraoptic nucleus; VMH, ventromedial
hypothalamus. Scale bar: 1mm
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Table 3. Comprehensive list of the studied brain regions in OVX CSO-vehicle and OVX hormone-treated female Syrian hamsters.
The addition symbol signifies TMEM35 protein expression. The presence of addition symbols in the OVX hormone-treated female
column indicate a significance difference in TMEM35 cell counts when compared to OVX CSO-vehicle, ++P < 0.05; +++P < 0.01; ++++P
< 0.0001

Brain Region
AH
AVPV
BNST
CA1
CA2
MA d
MCU
MNPO
MPN
Nacc
NAcsh
PVN
SCN
VMHm
VMHl

Vehicle
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

E2 + P
+++
+
+
++++
+
++
++
+
+
++ (P < 0.0862)
++
++++
+
+++
++ (P < 0.0657)
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Cottonseed oil

E2 + P

A

B

C

D

Figure 38. Representative images of ovarian hormone replacement on transmembrane 35-immunoreactive neuronal cell bodies in
anterior hypothalamus and CA1 of hippocampal formation. 10x photomicrographs showing TMEM35 immunoreactivity in anterior
hypothalamus (A,B) and CA1 of the Hippocampal formation (C,D) in cottonseed oil-treated and hormone-treated female the Syrian
hamster brains (right and left panels, respectively). 3V, 3rd ventricle. Scale bar: 1mm.
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Cottonseed Oil

E2 + P

A

B

C

D

Figure 39. Representative images of ovarian hormone replacement on transmembrane 35-immunoreactive neuronal cell bodies in
dorsal medial amygdala and medial caudate.10x photomicrographs showing TMEM35 immunoreactivity in dorsal medial amygdala
(A,B); medial caudate (C,D) in cottonseed oil-treated and hormone-treated female the Syrian hamster brains (right and left panels,
respectively). 3V, 3rd ventricle; cc, corpus callosum; LV, left ventricle; RV, right ventricle; ox, optic chiasm. Scale bar: 1mm.
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Cottonseed Oil
A

E2 + P
B

Figure 40. Representative images of ovarian hormone replacement on transmembrane 35-immunoreactive neuronal cell bodies in
nucleus accumbens. 10x photomicrographs showing TMEM35 immunoreactivity in nucleus accumbens shell (A,B) of cottonseed oiltreated and hormone-treated female Syrian hamster brains (right and left panels, respectively). 3V, 3rd ventricle. Scale bar: 1mm.
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Cottonseed Oil

E2 + P

A

B

C

D

Figure 41. Representative images of ovarian hormone replacement on transmembrane 35-immunoreactive neuronal cell bodies in
paraventricular nucleus and ventromedial hypothalamus. 10x photomicrographs showing TMEM35 immunoreactivity in
paraventricular nucleus (A,B); ventromedial hypothalamus medial and lateral, left and right boxes, respectively (C,D) in cottonseed
oil-treated and hormone-treated female the Syrian hamster brains (right and left panels, respectively). 3V, 3 rd ventricle. Scale bar:
1mm.
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Figure 42. Quantitative analysis of estrogen + progesterone treatment and CSO vehicle treatment on the number of TMEM35expressing nuclei in OVX-female Syrian hamster CNS. Histograms representing the TMEM35-positive cell counts in the anterior
hypothalamic nucleus (AH), CA1 of the hippocampal formation, dorsal medial amygdala (MAd), medial caudate (MCU), Nucleus
accumbens core (NAcc), nucleus accumbens shell (NAcsh), paraventricular nucleus (PVN), ventromedial hypothalamus medial
(VMHm), ventromedial hypothalamus lateral (VMHl) of CSO-treated vehicle (n=8, white bars) and hormone-treated (n=10, black
bars) females. *P < 0.05.
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DISCUSSION:
The present study investigated the effects of OVX and ovarian hormone replacement in
female Syrian hamster brain areas that were previously identified to be sexually dimorphic in
TMEM35 protein expression. Ovariectomy and hormone replacement are classical approaches
used to study estrogen and progesterone effects on the brain (“Ovariectomy/Gonadectomy,”
n.d.). Our results indicate that OVX females treated with ovarian hormones (to mimic the
natural estrous cycle) expressed greater levels of TMEM35-immunoreactive cells in several
hypothalamic and limbic regions compared to OVX females administered cottonseed oil vehicle.
Our data suggests that ovarian hormones may have activational effects on TMEM35 protein to
increase expression.
Previously in our laboratory, we demonstrated that a high number of TMEM35-positive
cells were localized in hypothalamic and limbic brain regions. Furthermore, we determined that
several of these regions displayed TMEM35 expression in a dimorphic manner, including the
AH, AVPV, BNST, DMH, LSd, MAd, MCU, MPN, NAcc, NAcsh, SCN, AND VMH. In our present
study, OVX female hamsters in the hormone-treated group exhibited a significant increase in
TMEM35 expression in the AH, CA1 of the hippocampal formation, MAd, MCU, NAcsh, PVN,
and VMHm. Each of these areas are rich in estrogen and progesterone receptors, which are
known to mediate their modulatory effects (Baudry et al., 2013; Guennoun et al., 2015;
Kruijver, Balesar, Espila, Unmehopa, & Swaab, 2003; Petersen et al., 2013; Warembourg &
Leroy, 2004).
The brain is an important target for gonadal hormones, specifically estrogen and
progesterone. Steroid receptors are localized within specific areas of the brain. This localization
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is important for ovarian hormones to mediate female-specific behaviors via classical and nonclassical membrane-associated receptors. A classic mechanism of cellular action for ovarian
hormones is the alteration of protein levels by transcriptional regulation (Carson-Jurica,
Schrader, & O’Malley, 1990). Thus, target proteins of estrogen (E2) and progesterone (P)
regulation are likely to have functional roles in one or more steroid-mediated effects on
behavior and brain function.
Our present study suggests that ovarian hormones may have an activational effect on
TMEM35 expression in the previously listed brain areas. Ovarian steroid hormones act via both
organizational and activational mechanisms. Organizational effects permanently organize the
nervous system during critical periods of growth and development, creating permanent,
irreversible changes in neural substrates that underlie behaviors (Elekonich & E. Robinson,
2000). In contrast, activational effects occur at any age in development and adulthood. These
effects are transient modifications that influence neuronal activity, which serve to alter the
behavioral state of an animal in response to social or environmental conditions (Elekonich & E.
Robinson, 2000). Previous work has demonstrated activational effects of ovarian hormones in
the AH, CA1, MAd, NAcsh, PVN, and VMH. For example, the VMH is a brain regions shown to be
critical target for ovarian hormones and mediating female sexual behaviors, such as lordosis
(Cohen & Pfaff, 1992; Malsbury et al., 1977). The anterior hypothalamus and paraventricular
hypothalamus are sensitive to facilitatory effects of ovarian hormones. In previous studies of
both, the AH (female voles) and PVN (female rats and rhesus monkeys), have implicated roles in
sexual behavior and maternal behavior via ovarian hormone modulation of neuropeptides, such
as corticotrophin-releasing hormone, oxytocin, and arginine vasopressin (Cushing & Carter,
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2000; Roy et al., 1999). As established through foundational studies by Pfaff, female sexual
motivation and desire are hormone sensitive and mediated (D. Pfaff, 2005; D. W. Pfaff, 1980,
1999). Recent studies have shown that ovarian hormones can enhance dopamine activity in the
nucleus accumbens of females, which may be important for mediating/encoding the rewarding
aspects of sexual behavior (Becker, 2005, 2016).
Numerous studies have investigated effects of estrogen on the enhancement of
hippocampal function, including neurogenesis, membrane excitability, cell morphology, and cell
signaling pathways (Spencer et al., 2008). Our present study demonstrated that ovarian
hormone administration to OVX female hamsters caused an increase in TMEM35 expression in
the CA1 of the hippocampal formation. Many investigators have provided evidence for
increased expression in other proteins such as brain-derived neurotrophic factor (BDNF)
following estradiol administration to OVX female rodents (Chan & Ye, 2017; Spencer et al.,
2008; Tao, Finkbeiner, Arnold, Shaywitz, & Greenberg, 1998). The mechanisms by which
estradiol interacts (direct or indirect) with proteins such as TMEM35 and BDNF remains to be
elucidated, and investigations into these mechanisms will further our understanding of the
effects of estrogen on the hippocampus.
The MA is rich in estrogen receptors and in female rodents has a functional role in
chemosensory-driven sexual behaviors (DiBenedictis et al., 2012). For example, in the MA an
increase in Fos expression was observed in mated females compared to non-mated females
(Flanagan-Cato & McEwen, 1995). However, the behavioral role that ovarian hormones play in
the MA of females remains unclear. Previous work has determined that knockout of the
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estrogen receptor within the MA have no observable effects on sexual behaviors in female
rodents (Spiteri et al., 2010).
In our study, we did not use naturally cycling females, but rather OVX females to
investigate the effects of ovarian hormone replacement on levels of TMEM35 protein
expression. Differences in TMEM35 expression may be due to differences in length of time that
females were ovariectomized (acute vs chronic), age of animal when E2 and P replacement
began, and mode of delivery (injection). Moreover, E2 and P may induce TMEM35 expression
directly by binding to a steroid response element (i.e. estrogen response element) on the
TMEM35 gene, or indirectly, via trans-synaptic connections, such as cyclic AMP response
element-binding protein pathway signaling. The mechanism by which ovarian hormones
stimulate TMEM35 protein expression remains to be determined. Therefore, future
investigations of transcriptional transactivation of TMEM35 by ovarian hormones may further
elucidate the underlying mechanisms controlling social and sex-specific behaviors.
Our results indicated that OVX females treated with ovarian hormones did not cause an
increase in TMEM35 protein levels in 8 of the 15 brain regions investigated. One potential cause
of this may be due to the molecular mechanism through which ovarian hormones exert their
actions in these brain regions. Ovarian hormones can have various regulatory effects based on
the differential expression of estradiol and progesterone receptor isoforms. For example,
estradiol receptor isoforms (receptors  and ) have been shown to produce opposing
molecular actions in specific brain regions (Matthews & Gustafsson, 2003; Temple et al., 2001).
Another possible explanation may be because of the specific roles in behavior each brain area
plays in females. Finally, this study only investigated the activational effects of ovarian
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hormones. The observed sex differences in the 8 brain areas may be due to the organizational
effects of steroid hormones, thus the removal of the ovaries followed by hormone replacement
would have no impact on TMEM35 levels.
In summary, we have demonstrated a relationship between ovarian hormones and
TMEM35 protein expression. Our findings suggest that treatment with ovarian hormones
induces TMEM35 protein expression in localized regions of the female hamster brain. Further,
these data provide indirect evidence that TMEM35 proteins and female sex-steroid receptors
are potentially co-localized within the same subpopulation of neurons. Based on this data, we
hypothesize that ovarian hormones may act as an endogenous regulator of TMEM35
expression. Due to the distribution patterns of TMEM35 in several brain regions that have
functions in social behavior, motivated and rewarding behaviors, and reproductive behaviors,
as well as the sex differences and reactivity to ovarian hormones, we need to determine if
social behaviors (such as sex behavior or other behaviors mediated by these structures) induces
expression of TMEM35.
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CHAPTER FIVE: DISCUSSION AND CONCLUSIONS

110

This thesis investigated the novel neuropeptide, transmembrane protein 35 (TMEM35).
TMEM35 is conserved across species and is thought to modulate signaling in the central
nervous system (CNS)10,11. This thesis and the results of our studies have demonstrated several
important and novel findings related to TMEM35.
The first aim of this thesis sought to examine the distribution pattern of TMEM35
protein in the male Syrian hamster brain. Prior to this work, one study had examined the role of
TMEM35 in the hypothalamic-pituitary-adrenal axis, including the amygdala and hippocampus
(Kennedy et al., 2016). Additionally, TMEM35 mRNA expression in the nervous system of mice
can be found in online databases (http://mouse.brain-map.org). Further, previous work
identified TMEM35 expression within in the spinal cord, however, both our study and the Allen
Brain Institute did not map the TMEM35 expression in the spinal cord. Therefore, future work is
need to determine TMEM35 protein expression patterns in the spinal cord.
We established a comprehensive and complete map of TMEM35 protein distribution to
develop an understanding of putative functions of TMEM35 in the nervous system. TMEM35
protein expression was both localized and widespread throughout the brain. Our results are
consistent with previously reported TMEM35 mRNA expression in mice (http://mouse.brainmap.org), indicating that mRNA distribution patterns are closely correlated with its
corresponding protein. Immunohistochemical and in situ hybridization (ISH) work in rodents
demonstrated that the largest population of TMEM35-positive cells exist within the olfactory,
hippocampal formation, hypothalamic, medulla, and limbic areas (Kennedy et al., 2016; Tran et
al., 2010). Compared to ISH in mice, however, immunohistochemistry in hamsters, based on a
qualitative observation, appears to detect fewer overall numbers of TMEM35 cells. The
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differences in cell numbers may be due to the species differences, as our study was conducted
in hamsters, whereas the others used mice as an animal model. Furthermore, studies at the
genome level are largely based on the assumption that mRNA expression is informative in
predicting protein expression level, however published data suggests that protein levels are not
proportional to mRNA (reviewed by Liu, Beyer, & Aebersold, 2016). This discordance is often
attributed to post-transcriptional, translational and protein-degradational regulation. Analyzing
mRNA and protein expression is not an exercise in redundancy because both are necessary for a
complete understanding of how the cell works (Greenbaum, Colangelo, Williams, & Gerstein,
2003). A limitation to our study is that we did not compare mRNA to protein expression in the
same species. This species difference may not reflect the connection between TMEM35 mRNA
and protein levels. Therefore, future studies should investigate the relationship between the
level of mRNA and protein within the same species, because potential quantification
differences between mRNA and protein levels may suggest important expression differences
between tissues or cell-types.
Strong expression levels were observed in several brain structures, such as the
hippocampal formation, hypothalamic, limbic, thalamic, and olfactory areas. Within these
regions, we identified several distinct cerebral nuclei in which TMEM35 was expressed
intensely, including the AVPV, NAc, MPN, SCN, SON, PIR, PVP. This distribution suggests a
putative role for TMEM35 in social behaviors including, sexual behavior, motivating/rewarding
behaviors, and reproductive behaviors (O’Connell & Hofmann, 2011; Parhar et al., 2016; Plant,
2015). Additionally, this study uncovered many unreported TMEM35-positive fibers in the SCN,
ARC, SON, BNST, PVN, DMH, AVPV, MPN, PMV, PVP. These data are consistent with findings of
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TMEM35 localization in the neurites (Kennedy et al., 2016). Our anatomical evidence is of
immense value in developing an understanding of the potential roles of TMEM35 in the
mammalian nervous system.
After mapping expression within males, we next aimed to investigate a previously
indicated sexual dimorphism in TMEM35 mRNA expression. To assess the potential dimorphism
in protein expression, we chose to focus on 44 specific brain areas where we found TMEM35
was highly expressed. Whereas overall distribution of TMEM35 was similar between males and
females, quantitative analysis revealed that males had consistently fewer immunoreactive cells
in the AH, AVPV, BNST, DMH, LSd, MAd, MCU, MPN, NAcc, NAcsh, SCN, and VMH compared to
females. The distribution and dimorphism of TMEM35 expression suggests a role in
physiological and behavioral systems, specifically in females.
The obvious difference between females and males is level of circulating gonadal
hormones and the influence of these hormones on the brain and behavior is well documented
(D. Pfaff, 2005; D. W. Pfaff & Joels, 2016; Xiao, Kondo, & Sakuma, 2004). Interestingly, the
TMEM35-expressing cells are localized in brain areas with abundant sex steroid receptors,
which suggests that this protein is sensitive to sex steroids. Furthermore, in several species, sex
differences have been found in the previously mentioned brain areas with dimorphic TMEM35
expression. Sex differences in these regions include, the brain volume (Barth et al., 2015), the
number, structure, and activity of cells (Schwarz & McCarthy, 2008), synaptic connectivity, and
neurochemical make-up (Carson-Jurica et al., 1990; Hansberg-Pastor et al., 2015).
Our data confirmed the previously described qualitative sex differences in TMEM35
mRNA expression with a quantitative analysis by directly comparing male to female TMEM35-
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positive cell. It can be hypothesized that the sex-specific expression of TMEM35 protein
potentially induces differential functions at both the neuronal and behavioral levels in each sex.
Considerations of sex differences in preclinical and clinical research will lead to improved
prevention, treatment, and overall health outcome in humans.
Due to the sexual dimorphism patterns of TMEM35 expression in in hypothalamic and
limbic regions of the rodent brain, coupled with the known functions of these structures, we
hypothesized that ovarian hormones have modulatory effects on TMEM35 expression patterns
in female Syrian hamsters. This study examined changes in TMEM35 expression following
ovarian hormone treatment. The work presented represents a first step in attempting to define
the effects of circulating steroids on TMEM35 expression in the Syrian hamster brain.
The administration of gonadal steroids resulted in a marked increase in numbers of
neurons that expression TMEM35 protein compared to ovariectomized controls. A significant
increase in TMEM35 expression in hormone-treated females was observed in the AH, CA1,
MAd, MCU, NAcsh, PVN, and VMH. The effects of gonadal hormones can be classified as
organizational or activational. Organizational effects are permanent and act during
development; activational effects of hormones are transient and often triggered by cues from
the environment (Arnold, 2009). Collectively, these results demonstrate a relation between
TMEM35 levels and ovarian hormones. Our findings suggest that treatment with ovarian
hormones induces TMEM35 protein expression in localized regions of the female hamster
brain. Further, these data provide indirect evidence that TMEM35 proteins and female sexsteroid receptors are potentially co-localized within the same subpopulation of neurons. Based
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on this data, we hypothesize that ovarian hormones may act as an endogenous regulator of
TMEM35 expression.
While ovarian hormone treatment did increase TMEM35 levels, it is not known if there
is a differential effect of the different ovarian steroids on TMEM35 expression. In females,
hormonal variations occur within the estrous cycle. Briefly, female rodents exhibit a 4-day
estrous cycle, during which there is an initial increase in estradiol levels followed by a surge in
circulating progesterone levels that bind to their respective receptors in the brain (Jeffrey D
Blaustein, 2002; Kow & Pfaff, 1975; Miller & Takahashi, 2014). The brain is an important target
for estrogen and progestin effects. Estrogen exerts a wide variety of effects on function and
structure of the brain. While both hormones have important roles in brain structure and
function, the effects of estrogen are more extensively studied. Estrogen is important in
reproductive behaviors (Barth et al., 2015; Miller & Takahashi, 2014; Xiao et al., 2004),
motivation (Yoest, Cummings, & Becker, 2014), social behaviors (Bos et al., 2012), learning and
memory (F. Liu et al., 2008), emotion (Amin, Epperson, Constable, & Canli, 2006), brain
development and plasticity (Baudry et al., 2013; Schwarz & McCarthy, 2008), neurite outgrowth
and synaptogenesis (Haraguchi et al., 2012), and dendritic branching (Cooke & Woolley, 2005).
Furthermore, in distinct regions progesterone receptor expression is dependent upon the
activation of estradiol receptors (Blaustein, Olster, & Tetel, 1993). Progestin has multiple
functions in the central nervous system including, regulating cognition and mood (D. Pfaff,
2005), reproductive behaviors (Argiolas & Melis, 2013; Barth et al., 2015), modulating estrogen
action (Bimonte-Nelson et al., 2004; Murphy & Segal, 2000), and neurogenesis and
regeneration (Baudry et al., 2013; Guennoun et al., 2015). Previous work has shown differential
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impacts of estrogen treatment and progesterone treatment alone than estrogen combined with
progesterone; thus, future studies are needed to determine the effects of each individual
ovarian hormones on TMEM35 protein expression.
Overall, this work successfully mapped TMEM expression, described sex differences in
expression and determined that those sex differences were at least in part due to circulating
ovarian hormones in females. It is worth noting that the function of TMEM35 in the majority of
brain areas reported in the present study and previous studies (Chapters 2 and 3) remain
unknown. To date, a study conducted by Kennedy et al. implicated a role TMEM35 in the
hypothalamic-pituitary-adrenal axis and limbic circuit. This study assessed TMEM35 role in
behaviors, such as fear and spatial learning (Kennedy et al., 2016). Dysregulation of these brain
regions are often associated with psychological disorders, including depression and addiction
(Becker, 2016; Gardner, 2011; Valerie L. Hedges et al., 2010b). Characterizing how TMEM35
expression is altered as a result of in engaging in normal life experiences, including sexual
behavior, will give insight into the biology of these brain networks, provide better
understanding into how these systems function, and potentially lead to the development of
therapeutic treatments to alleviate dysfunctions within each network. Our investigation of
TMEM35 protein expression indicates a potential role for this protein in these psychological
disorders, thus, the putative sex-specific effects of this peptide on these networks requires
further investigation.
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APPENDIX A
Table A.1. Supplementary abbreviations
Abbreviation Name
3 oculomotor nucleus
3V 3rd ventricle
4 trochlear nucleus
4V 4th ventricle
6 abducens nucleus
7 facial nucleus
7n facial nerve
8n vestibulocochlear nerve
8vn vestibulocochlear root
ac
aca
ACo
AD
AH
AHi
AID
AIP
AIV
AM
AOD
AOL
AOM
AOP
APT
Aq
ARC
AU
AV
AVPV
Bar
BIC
bic
BLA
BLP
BMA
BNST
BNSTP I/L/M
CA1
CA2
CA3
Cb 1-10
cc
Ce

anterior commissure
anterior commissure, anterior part
anterior cortical amygdaloid nucleus
anterodorsal thalamic nucleus
anterior hypothalamus
amygdalohippocampal area
agranular insular cortex, dorsal part
agranular insular cortex, posterior part
agranular insular cortex, ventral part
anteromedial thalamic nucleus
anterior olfactory nucleus, dorsal part
anterior olfactory nucleus, lateral part
anterior olfactory nucleus, medial part
anterior olfactory nucleus, posterior part
anterior pretectal nucleus
aqueduct
arcuate hypothalamic nucleus
auditory cortex
anteroventral thalamic nucleus
anterioventral periventricular nucleus

Abbreviation
m5
MA3
mcp
MD
Me AD/AV
Med
MEnt
MePD
MG
MGM
ml
mlf
MM
MnPO
MnR
MO5
MPAG
MPN
MPO
MRe
MS
mt
mtg
MVe
NAcc
NAcsh
NDB
Op
ORB
ot
OVLT
ox

Barrington's nucleus
brachium of the inferior colliculus
brachium of the inferior colliculus
basolateral amygdaloid, anterior part
basolateral amygdaloid, posterior part
basomedial amygdaloid, anterior part
bed nucleus of the stria terminalis
BNST (posterointermediate/lateral/medial)

PAG
PBP
pc
PC t
PDTg
Pir
PL
PLC o
PMC o
PMnR
PMV

field CA1 of the hippocampus
field CA2 of the hippocampus
field CA3 of the hippocampus
cerebellar lobule (1-10)
corpus callosum
central amygdaloid nucleus
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Name
motor root of the trigeminal nerve
medial accessory oculomotor nucleus
middle cerebellar peduncle
mediodorsal thalamic nucleus
medial amygdaloid (anterodorsal/ventral)
medial cerebellar nucleus
medial entorhinal cortex
medial amygdaloid, posterodorsal part
medial geniculate nucleus
medial geniculate nucleus, medial part
medial lemniscus
medial longitudinal fasciculus
Medial mammillary nucleus
median preoptic nucleus
median raphe nucleus
motor trigeminal nucleus
medial periaqueductal gray
medial preoptic nucleus
medial preoptic area
mammillary recess of the 3rd ventricle
medial septal nucleus
mammillothalamic tract
mammillotegmental tract
medial vestibular nucleus
Nucleus accumbens core
Nucleus accumbens shell
nucleus of the diagonal band of Broca
optic nerve layer of the superior colliculus
orbital cortex
optic tract
organum vasculosum of the lamina terminalis
optic chiasm
periaqueductal gray
parabrachial pigmented nucleus
posterior commissure
paravicellular reticular nucleus
posterodorsal tegmental nucleus
piriform cortex
Paralemniscal nucleus
posterolateral cortical amygdaloid nucleus
posteromedial cortical amygdaloid nucleus
paramedian raphe nucleus
Premammillary nucleus, ventral part

Cg 1-2
CGM
CGPn
CIC
cic
Cl
CLi

cingulate cortex (area 1/2)
central gray, medial part
central gray of the pons
central nucleus of the inferior colliculus
commissure of the inferior colliculus
claustrum
caudal linear nucleus of the raphe

CM
CnF
CPu
Crus 1-2

central medial thalamic nucleus
cuneiform nucleus
caudate putamen (striatum)
crus 1/2 of the ansiform lobule

D3V
DA
DC
DEn
DG
DI
Dk
DLG
DM
DMPAG
DP
DpG
DPGi
DpMe
DR
DTg
dtgx
DTM
DTT

dorsal 3rd ventricle
dorsal hypothalamic area
dorsal cochlear nucleus
dorsal endopiriform nucleus
dentate gyrus
dysgranular insular cortex
nucleus of Darkschewitsch
dorsal lateral geniculate nucleus
dorsal medial hypothalamic nucleus
dorsomedial periaqueductal gray
dorsal peduncular cortex
deep gray layer of the superior colliculus
dorsal paragigantocellular nucleus
deep mesencephalic nucleus
dorsal raphe nucleus
dorsal tegmental nucleus
dorsal tegmental decussation
dorsal tuberomammillary nucleus
dorsal tenia tecta

ECIC
EW

PN
Pn
PnO
PnR
PO
PoMn

fornix
fimbria of hippocampus
flocculus
forceps minor of the cc
forceps major of the cc
fasciculus retroflexus

g7
gcc
GI
Gi
GiA
GlA
GP

genu of the facial nerve
genu of the corpus callosum
granular insular cortex
gigantocellular reticular nucleus
gigantocellular reticular nucleus, alpha part
glomerular lay of the accessory olfactory bulb
globus pallidus

Re
RIP
RLi
RMC
RMg
ROb
RPa
RPO
RRF
rs
RSA
RSG
Rt
RtTg
RtTgP

reuniens thalamic nucleus
raphe interpositus nucleus
rostral linear nucleus of the raphe
red nucleus, magnocellular part
raphe magnus nucleus
raphe obscurus nucleus
raphe pallidus nucleus
rostral periolivary region
retrorubral field
rubrospinal tract
retrosplenial agranular cortex
retrosplenial granular cortex
reticular thalamic nucleus
reticulotegmental nucleus of the pons
RtTg, pericentral part

PoT

external cortex of the inferior colliculus
Edinger-Westphal nucleus

f
fi
FI
fmi
fmj
fr

PP
PPT
PPTg
PR
Pr
Pr5
PrL
PT
PVA/P
PVN
py

paranigral nucleus
pontine nuclei
pontine reticular nucleus, oral part
pontine raphe nucleus
paraolivary nucleus
posteromedian thalamic nucleus
posterior thalamic nuclear group, triangular
part
peripeduncular nucleus
posterior pretectal nucleus
pedunculopontine tegmental nucleus
prerubral field
prepositus nucleus
principle sensory trigeminal nucleus
prelimbic cortex
paratenial thalamic nucleus
paraventricular thalamic (anterior/posterior)
paraventricular hypothalamic nucleus
pyramidal tract

S
S 1-2
SCN
SFi
SFO
SHi
SI
Sim A-B
SM
sm
SNC
SNL
SNR
SO
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subiculum
somatosensory cortex (primary/secondary)
suprachiasmatic nucleus
septofimbrial nucleus
subfornical organ
septohippocamal nucleus
substantia innominata
simple lobule (A/B)
nucleus of striat medullaris
stria medullaris of the thalamus
substantia nigra central part
substantia nigra lateral part
substantia nigra reticular part
superior olive

Hb
IAM
ic
IL
ILL
IMD
InCo

habenular nucleus

IPC
IPD L/M
IPF
IPI
IPL
IPR

interanteromedial thalamic nucleus
internal capsule
Infralimbic cortex
intermediate nucleus of the lateral lemniscus
intermediodorsal thalamic nucleus
intercollicular nucleus
intermediate gray layer of the superior
colliculus
interposed cerebellar nucleus
interposed cerebellar, posterior part
intermediate white layer of the superior
colliculus
interpeduncular nucleus, caudal subnucleus
IP nucleus, dorsolateral/medial subnucleus
interpeduncular fossa
IP nucleus, intermediate subnucleus
interpeduncular nucleus, lateral subnucleus
interpeduncular nucleus, rostral subnucleus

Lat
LC
LD
LEnt
lfp
LH
ll
LP
LPAG
LPO
LS D/I/V
LSS
LV
LVe

lateral cerebellar nucleus
locus coeruleus
lateral dorsal thalamic nucleus
lateral entorhinal cortex
longitudinal fasciculus of the pons
lateral hypothalamic area
lateral lemniscus
lateral posterior thalamic nucleus
lateral periaqueductal gray
lateral preoptic area
lateral septal, (dorsal/intermediate/ventral)
lateral stripe of striatum
left ventricle
lateral vestibular nucleus

InG
Int
IntP
lnWh

M
M 1-2

sol
SON
SOR
Sp5
SpVe
sp5
st
SuG
SuM

solitary tract
supraoptic nucleus
supraoptic nucleus, retrochiasmatic part
spinal trigeminal nucleus
spinal vestibular nucleus
spinal trigeminal tract
stria terminalis
superficial gray layer of the superior colliculus
supramammillary nucleus

SuML

supramammillary nucleus lateral

SuVe

superior vestibular nucleus

TS

triangular septal nucleus

ts
Tz
tz

tectospinal tract
nucleus of the trapezoid body
trapezoid body

V1
V2 L-M
VEn
VLG
VLL
VM
VMH L/M
VP
VPL
VPM
vsc
VTA
VTg
vtt
Xi
ZIL
ZIM
Zo

motor cortex
motor cortex (primary/secondary)
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primary visual cortex
2ndary visual cortex (lateral/medial)
ventral endopiriform nucleus
ventral lateral geniculate nucleus
ventral nucleus of the lateral lemniscus
ventromedial thalamic nucleus
ventromedial hypothalamic (lateral/medial)
ventral pallidum
ventral posterolateral thalamic nucleus
ventral posteromedial thalamic nucleus
ventral spinocerebellar tract
ventral tegmental area
ventral tegmental nucleus
ventral tenia tecta
xiphoid thalamic nucleus
zona incerta lateral
zona incerta medial
zonal layer of the superior colliculus
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